Robert R. Recker, MD
Robert R. Recker, MD

Robert R. Recker, MD

Professor
School of Medicine

Academic Appointments

Department

  • Medicine

Position

  • Professor

Education

  • Creighton University School of Medicine,M.D.,to 1963

Publications and Presentations

Books

  • Johnson ML, Recker RR. Wnt6 signaling in bone. Osteoporosis 3rd Edition: 467-490, 2007., Academic Press, 3rd Edition, 467-490, 2007
  • , Not Applicable, Unknown, 2007
  • Recker RR, Lappe J, Davies KM, Heaney RP,: Bone remodeling: biochemical markers or bone biopsy?: J Bone Miner Res 21:180, 2006., J. Bone Miner. Res., 2006
  • Fox J, Miller MA, Newman MK, Recker RR, Turner CH, Smith SY: Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult overiectomized rhesus monkeys: Bone,41: 321-330, 2007., Not Applicable, 2006
  • Delmas PD, Adami S, Strugala C, Stakkestad JA, Reginster J-Y, Felsenberg D, Christiansen C, Civitelli R, Drezner MK, Recker RR, Bolognese M, Hughes C, Masanauskaite D, Ward P, Sambrook P, Reid DM: Intravenous ibandronate injections in postmenopausal women with osteoporosis: Arthritis Rheum 54: 1838-1846, 2006., Arthritis & Rheumatism, 2006

Articles

  •  Vennin S, Desyatova A, Turner JA, Watson P, Lappe J, Recker RR, Akhter MP. Intrinsic Material Property Differences in Bone Tissue from Patients Suffering Low-Trauma Osteoporotic Fractures, Compared to Matched Non-fracturing Women. Bone 2017 Jan 26. pii: S8756-3282(17)30031-5. doi: 10.1016/j.bone.2017.01.031. [Epub ahead of print] PMID: 28132909, Bone, 2017
  • Zhang M, Zhao L, Zhou Y, Badr R, Watson P, Ye A, Zhou B, Zhang J, Deng H, Recker R, Lappe J. SNP rs11185644 of RXRA gene is identified for dose-response variability to vitamin D3 supplementation: a randomized clinical trial.  Scientific Reports Jan 12;7:40593. doi: 10.1038/srep40593. PMID: 28079136 PMCID: PMC5228186, Scientific Reports, 2017
  • Moreira C, Fitzpatrick L, Wang Y, Recker R. Effects of Abaloparatide-SC(BA058) on bone histology and histomorphometry: The ACTIVE phase 3 trial. Bone. 2016 Nov 5. pii: S8756-3282(16)30329-5. doi: 10.1016/j.bone.2016.11.004. [Epub ahead of print] PMID: 27826127 DOI: 10.1016/j.bone.2016.11.004, Bone, 2016
  • Recker R, Lappe J. In Memoriam: Robert P Heaney, M.D. J Bone Miner Res. 2016 Aug 20. doi: 10.1002/jbmr.2981. [Epub ahead of print] PMID: 27543924, Journal of Bone and Mineral Research, 2016
  • Farlay D, Armas L, Gineyts E, Akhter M, Recker R, Boivin G. Non-enzymatic glycation and degree of mineralization are higher in bone from fractured patients with Type 1 Diabetes Mellitus. J Bone Miner Res 2015 Aug 1 [Epub ahead of print] PMID: 26234180, J Bone Miner Res, 2015, 2016
  • Wallace T, Bauer D, Gagel R, Greenspan S, Lappe J, LeBoff M, Recker R, Saag K, Singer A. The National Osteoporosis Foundation’s methods and processes for developing position statements. Osteoporos Int, 2016 Dec;11(1):22. doi: 10.1007/s11657-016-0276-1. Epub 2016 May 26. PMID: 27229335, Osteoporosis International, 11(1), 2016
  • Dempster DW, Zhou H, Recker RR, Brown JP, Recknor CP, Lewiecki EM, Miller PD, Rao SD, Kendler DL, Lindsay R, Krege JH, Alam J, Taylor KA, Janos B, Ruff VA. Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study. J Clin Endocrinol Metab. 2016 Apr;101(4):1353-63. doi: 10.1210/jc.2015-4181. Epub 2016 Feb 9. PubMed PMID: 26859106., J Clin Endocrinol Metab, 2016 Apr; 101(4), 1353-63, 2016
  • Ascenzi MG, Chin J, Lappe J, Recker R. Non-osteoporotic women with low-trauma fracture present altered birefringence in cortical bone. Bone. 2016 84:104-112. PMID: 26514952., Bone, 2016 84, 104-112, 2016
  • Dempster DW, Zhou H, Recker RR, Brown JP, Bolognese MA, Recknor CP, Kendler DL, Lewiecki EM, Hanley DA, Rao SD, Miller PD, Woodson GC 3rd, Lindsay R, Binkley N, Alam J, Ruff VA, Gallagher ER, Taylor KA. A Longitudinal Study of Skeletal Histomorphometry at 6 and 24 Months Across Four Bone Envelopes in Postmenopausal Women with Osteoporosis Receiving Teriparatide or Zoledronic Acid in the SHOTZ Trial. J Bone Miner Res 2016 Feb 3 [Epub ahead of print] PMID: 26841258., J Bone Miner Res, 2016 Feb 3, 2016
  • Farlay D, Armas L, Gineyts E, Akhter M, Recker R, Boivin G. Non-enzymatic glycation and degree of mineralization are higher in bone from fractured patients with type 1 diabetes mellitus. J Bone Miner Res 2015 Aug 1 [Epub ahead of print]. PMID: 26234180., J Bone Miner Res, 2016 Jan;31(1), 190-5, 2016
  • Misof BM, Roschger P, Blouin S, Recker R, Klaushofer K. Bone matrix mineralization is preserved during early perimenopausal stage in healthy women: a paired biopsy study. Osteoporos Int 2015 Dec 9 [Epub ahead of print]. PMID: 26650378., Osteoporosis International, 2015 Dec 9, 2015
  • Boskey A, Recker R, Boskey E, Lappe J, Ma Y, Zhang W, Spevak M, Watson P. Examining the Relationships between Bone Tissue Composition, Compositional Heterogeneity and Fragility Fracture: A Matched Case Controlled FTIRI Study. J Bone Miner Res. 2015 Dec 4 [Epub ahead of print]. PMID: 26636271., J Bone Miner Res, 2015 Dec 4, 2015
  • Cohen A, Kamanda-Kosseh M, Recker R, Lappe J, Dempster D, Zhou H, Cremers S, Bucovsky M, Stubby J, Shane E. Bone density after teriparatide discontinuation in premenopausal idiopathic osteoporosis. J Clin Endocrinol Metab 2015 Nov;100(11):4208-4214. PMID: 26358172., Journal of Clinical Immunology, 2015 Nov; 100(11), 4208-4214, 2015
  • Cohen A, Shen W, Dempster D, Zhou H, Recker R, Lappe J, Kepley A, Kamanda-Kosseh M, Bucovsky M, Stein E, Nickolas T, Shane E. Marrow adiposity assessed on transiliac crest biopsy samples correlates with noninvasive measurement of marrow adiposity by magnetic resonance spectroscopy (1H-MRS) at the spine but not the femur. Osteoporos Int 2015 Oct;26(10):2471-2478. PMID: 25986383., Osteoporosis International, 2015 cot 26(10), 2471-2478, 2015
  • Paschalis EP, Fratzl P, Gamsjaeger S, Hassler N, Brozek W, Eriksen EF, Rauch F, Glorieux FH, Shane E, Dempster D, Cohen A, Recker R, Klaushofer K. Aging vs Postmenopausal Osteoporosis: bone composition and maturation kinetics at actively forming trabecular surfaces of female subjects aged 1 to 84 years old. J Bone Miner Res 2015 Aug 26 [Epub ahead of print]. PMID: 26308158., J Bone Miner Res, 2015 Aug 26, 2015
  • Carballido-Gamio J, Bonaretti S, Saeed I, Harnish R, Recker R, Burghardt A, Keyak J, Harris T, Khosla S, Lang T. Automatic multi-parametric quantification of the proximal femur with quantitative computed tomography. Quantitative Imaging in Medicine and Surgery 2015 Aug;5(4):552-568. PMID: 26435919., Quantitative Imaging in medicine and Surgery, 2015 Aug;5(4), 552-568, 2015
  • Barrett-Connor E, Wade SW, Downs RW, Ganiats T, Hochberg M, Recker RR, Stolshek BS. Self-reported calcium use in a cohort of postmenopausal women receiving osteoporosis therapy: results from POSSIBLE US™. Osteoporos Int 2015 Aug;26(8):2175-2184. PMID: 25876880., Osteoporosis International, 2015 Aug:26(8), 2175-2184, 2015
  • Recknor CP, Recker RR, Benson CT, Robins DA, Chiang AY, Alam J, Hu L, Matsumoto T, Sowa H, Sloan JH, Konrad RJ, Mitlak BH, Sipos AA. The effect of discontinuing treatment with blosozumab: Follow-up results of a phase 2 randomized clinical trial in postmenopausal women with low bone mineral density. J Bone Miner Res Feb 24 [Epub ahead of print] PMID: 25707611., J Bone Miner Res, 2015 Feb 24, 2015
  • Recker RR, Benson CT, Matsumoto T, Bolognese MA, Robins DA, Alam J, Chiang AY, Hu L, Krege JH, Sowa H, Mitlak BH, Myers SL. A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density. J Bone Miner Res 2015 Feb;30(2):216-224. PMID: 25196993., J. Bone Miner. Res., 30(2), 216-224, 2015
  • Recker RR, Ste-Marie L-G, Chavassieux P, McClung MR, Lundy MW. Bone safety with risedronate: histomorphometric studies at different dose levels and exposure. Osteoporos Int. 2015 Jan;26(1):327-337. PMID: 25304456., Osteoporosis International, 26(1), 327-337, 2015
  • Tarasova, V.D., Nahar, N.N., Dietz, N., Recker, R.R., Anderson, R.J. Unique Occurrence and Course in a Patient with PTEN Hamartoma Tumor Syndrome and Graves’Disease. Letters to the Editor, Endocr Pract 20 (No.12) 1-2, December, 2014., Endocrine Practice, 20 No.12, 1-2, 2014
  • Zhou QH, Zhao LJ, Wang P, Badr R, Xu XJ, Bu FX, Lappe J, Recker R, Zhou Y, Ye A, Zhou BT. Comprehensive analysis of the association of EGFR, CALM3 and SMARCD1 gene polymorphisms with BMD in Caucasian women. PLoS One 2014 Nov 14;9(11):e112358. PMID: 25396734. PMCID: PMC4232396., PLoS One, 9(11), e112358, 2014
  • Misof BM, Dempster DW, Zhou H, Roschger P, Fratzl-Zelman N, Fratzl P, Sliverberg SJ, Shane E, Cohen A, Stein E, Nickolas TL, Recker RR, Lappe J, Bilezikian JP, Klaushofer K. Relationship of bone mineralization density distribution (BMDD) in cortical and cancellous bone within the iliac crest of healthy premenopausal women. Calcif Tissue Int. 2014 Oct. 95(4):332-339. PMID: 25134800., Calcif Tissue Int, 95(4), 332-339, 2014
  • Zhou Y, Zhao LJ, Xu X, Ye A, Travers-Gaustafson D, Zhou B, Wang HW, Zhang W, Hamm LL, Deng HW, Recker RR, Lappe JM. DNA methylation levels of CYP2R1 and CYP24A1 predict vitamin D response variation. J. Steroid Biochem. Mol. Biol. 2014 Oct;144 PtA:207-214. PMID: 24128439. PMCID: PMC3984616., Journal of Steroid Biochemistry and Molecular Biology, 2014 Oct: 144PtA, 207-214, 2014
  • Nishiyama KK, Cohen A, Young P, Wang j, Lappe JM, Guo XE, Dempster DW, Recker RR, Shane E. Teriparatide increases strength of the perifheral skeleton in premenopausal women with idiopathic osteoporosis: A pilot HR-pQCT Study. J Clin Endocrinol Metab. 2014 Jul;99(7):2418-25. Epub 2014 Mar 31. PMID: 24684466. PMCID: PMC4079304., J Clin Endocrinol Metab, 2014 July:99(7), 2418-25, 2014
  • Cao Z, Moore BT, Wang Y, Peng XH, Lappe JM, Recker RR, Xiao P. MiR-422a as a potential cellular microRNA biomarker for postmenopausal osteoporosis. PloS One. 2014 May 12;9(5)e97098. PMID: 24820117. PMCID: PMC4018259., PLoS One, 2014 May 12; 9(5), e97098, 2014
  • Gamsjaeger S, Brozek W, Recker R, Klaushofer K, Paschalis E. Transmenopausal changes in trabecular bone quality. J Bone Miner Res, 2014 March 29(3):608-617. PMID: 23966337., J Bone Miner Res, 2014 March 29(3), 608-617, 2014
  • Miller P, Recker R, Harris S, Silverman S, Felsenberg D, Reginster J, Day B-M, Barr C, Masanauskaite D. Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies. Osteoporos Int. 2014 Jan;25(1):349-357. PMID: 24136103., Osteoporosis International, 2014 Jan:25(1), 349-357, 2014
  • Tarasova VD, Trepp-Carrasco AG, Thompson R, Recker RR, chong WH, Collins MT, Armas LA. Successful treatment of tumor-induced osteomalacia due to an intracranial tumor by fractionated stereotactic radiotherapy. J Clin Endocrinol Metab. 2013 Nov;98(11);4267-72. Epub 2013 Sep 6. PMID: 24014621., J Clin Endocrinol Metab, 2013 Nov;98(11), 4267-72, 2013
  • Recker RR., Bone biopsy and histomorphometry in clinical practice., Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 8th edition, Chapter IV, pp. 307-316. ASBMR, Wiley-Blackwell Publishers, 2013., Not Applicable, 8th edition, Chapter IV, 307-316, 2013
  • Kruger PC, Parsons PJ, Galusha AL, Morrissette M, Recker RR, Howard LJ. Excessive aluminum accumulation in the bones of patients on long-term parenteral nutrition: postmortem analysis by electronthermal atomic absorption spectrometry. J Parenter Enteral Nutr. 2013 Aug 38(6):728-735. PMID: 23765064., J Parenter Enteral Nutr, 2013 Aug 38(6), 728-735, 2013
  • Wang J, Zhang X, Ma D, Lee WN, Xiao J, Zhao Y, Go VL, Wang Q, Yen Y, Recker R, Xiao GG. Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cells. Exp Hematol Oncol. 2013 July 27;2(1):18. PMID: 23890079. PMCID: PMC3733980., Exp Hematol Oncol, 2013 July 27; 2(1), 18, 2013
  • Chen P, Miller PD, Recker R, Resch H, Rana A, Pavo I, Sipos,AA: Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis: J Bone Mine Res, 22: 1173-1180, 2007., Journal of Bone and Mineral Research, 2007
  • Tang Z-H, Xiao P, Lei S-F, Deng F-Y, Zhao L-J, Deng H-Y, Tan L-J, Shen H, Xiong D-H, Recker RR, Deng H-W: A bivariate whole-genome linkage scan suggests several shared genomic regions for obesity and osteoporosis: J Clin Endocrinol Metab, 92:2751-2757, 2007., J. Clin Endo. and Metab., 2007
  • Ioannidis,JPA, Ng MY, Sham PC, Zintzaras E, Lewis CM, Deng H-W, Econs MJ, Karasik D, Devoto M, Kammerer CM, Spector T, Andrew T, Cupples LA, Duncan EL, Foroud T, Kiel DP, Koller D, Langdahl B, Mitchell BD, Peacock M, Recker R, Shen H, Sol-Church K,Spotila LD, Uitterlinden AG, Wilson SG, Kung AWC, Ralston SH: Meta-analysis of genome-wide scans provides evidence for sex- and site-specific regulation of bone mass: J. Bone Miner Res 22: 173-183, 2007., J. Bone Miner. Res., 2007
  • Fox J, Miller MA, Newman MK, Turner CH, Recker RR, Smith SY: Treatment of skeletally mature ovariectomized Rhesus monkeys with PTH(1-84) for 16 months increases bone formation and density and improves trabecular architecture and biomechanical properties at the lumbar spine: J.Bone Miner Res 22: 260-273, 2007, J. Bone Miner. Res., 2007
  • Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP: Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial: Am J Clin Nutr 85: 1586-1591, 2007., American Journal of Clnical Nutrition, 2007
  • Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP: Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial.: Am J Clin Nutr, 85:1586-1591, 2007., American Journal of Clinical Pathology, 2007
  • Recker RR, Delmas PD, Reid I, Boonen SR, Halse J, Supronik J, Garcia P, Hartl F, Mesenbrink P, Gasser J, Ericksen EF: Histomorphometric and micro-CT analysis of bone bipsies after 3 annual infusions of zoledronic acid 5 mg: Evidence for preservation of bone structure and remodeling capacity:Bone Supplement 2007; 40:S133-S134., Bone, 2007
  • Recker RR, Miller PD, Ste-Marie L, Phipps RJ, Zhou X, Seeman E:Comparison of risedronate and alendronate on bone remodeling and on trabecular and cortical bone architecture; a cross-sectional study in women with postmenopausal osteoporosis on long-term bisphosphonate therapy: Bone Supplement 2007; 40:S260-S260., Bone, 2007
  • Recker RR, Masanauskaite D, Ethgen D, Enslin MB: Micro computed tomography from the BONE study: Daily oral ibandronate preserves trabecular microarchitecture:Bone Supplement 2007; 40:S300-S301, Bone, 2007
  • Recker RR, Kendler D, Recknow,CP, Rooney,TW, Lewiecki EM, Utian WH, Cauley JA, Lorraine J, Qu Y, Kulkarni PM, Gaich CL, Wong M, Plouffe L, Stock JL: Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass: Bone, 2006., Bone, 2006
  • Xiao P, Shen H, Guo Y-F, Xiong D-H, Liu Y-Z, Liu Y-J, Zhao L-J, Long J-R, Guo Y, Recker RR, Deng H-W: Genomic regions identified for BMD in a large sample including epistatic interactions and gender-specific effects. J Bone Miner Res 21:1536-1544, 2006, J. Bone Miner. Res., 2006
  • Durchschlag E, Paschalis EP, Zoehrer R, Roschger P, Fratzl P, Recker R, Phipps R, Klaushofer K: Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate. J Bone Miner Res 21:1581-1590, 2006, J. Bone Miner. Res., 2006
  • Liu Y-J, Shen H, Xiao P, Xiong D-H, Li L-H, Recker RR, Deng H-W: Molecular genetic studies of gene identification for osteoporosis: a 2004 update. J Bone Miner Res 21:1511-1535, 2006, J. Bone Miner. Res., 2006
  • Barger-Lux MJ, Recker RR: Toward understanding bone quality – transilial bone biopsy and bone histomorphometry: Clinical Reviews in Bone and Mineral Metabolism 4:167-175, 2006, Clinical Reviews in Bone and Mineral Metabolism, 2006
  • Zhao L-J, Liu P-Y, Recker R, Deng H-W: Correlation of transmenopausal bone mass in healthy, white women: a long-term longitudinal study: Osteoporos Int 17:1501-1505, 2006, Osteoporosis International, 2006
  • Mellibovsky L, Diez A, Perez-Vila E, Serrano S, Nacher M, Aubia J, Supervia A, Recker RR: Vitamin D treatment in myelodysplastic syndromes. British Journal of Haematology 100:516-520, 1998, British Journal of Haematology, 2006
  • Xiong D-H, Shen H, Xiao P, Guo Y-F, Long J-R, Zhao L-J, Liu Y-Z, Deng H-Y, Li J-L, Recker RR, Deng H-W: Genome-wide scan identified QTLs underlying femoral neck cross-sectional geometry that are novel studied risk factors of osteoporosis. J Bone Miner Res 21:424-437, 2006, J. Bone Miner. Res., 2006
  • Reginster J-Y, Felsenberg D, Cooper C, Stakkestad JA, Miller PD, Kendler DL, Adami S, McClung MR, Bolognese MA, Civitelli R, Dumont E, Bonvoisin B, Recker RR, Delmas PD: A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate. Osteoporos Int 17:159-166, 2006, Osteoporosis International, 2006
  • Huang Q-Y, Shen H, Deng H-Y, Conway T, Elze L, Davies KM, Recker RR, Deng H-W: CA repeat polymorphism of the TNFR2 gene is not associated with bone mineral density in two independent Caucasion populations: J Bone Miner Metab 24:132-137, 2006, J. Bone Miner. Res., 2006
  • Recker R, Lips P, Felsenberg D, Lippuner K, Benhamou L, Hawkins F, Delmas PD, Rosen C, Emkey R, Salzmann G, He W, Santora AC: Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial: Current Medical Research and Opinions 22:1745-1755, 2006, Current Medical Research and Opinion, 2006
  • Chen X-D, Shen H, Recker RR, Deng H-W: Linkage exclusion mapping with bone size in 79 Caucasion pedigrees: J Bone Miner Metab 24:337-343, 2006, J. Bone Miner. Res., 2006
  • Recker R, Lips P, Felsenberg D, Lippuner K, Benhamou L, Hawkins-Carranza R, Delmas PD, Rosen C, Emkey R, Salzmann G, He W, Santora AC: Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial. ASBMR 2005; submitted, ASE, 2006
  • Xiong D-H, Shen H, Zhao L-J, Xiao P, Yang T-L, Guo Y, Wang W, Guo Y-F, Liu Y-J, Recker RR, Deng H-W: Robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene-gene interaction: J Bone Miner Res 21:1678-1695, 2006, J. Bone Miner. Res., 2006
  • Johnson ML, Recker RR: Wnt signaling in bone. Submitted 2006, Neurosurgery Clinics North America, 2006
  • Recker RR, Barger-Lux MJ,: Ibandronate for prevention and treatment of osteoporosis in postmenopausal women. Expert Review in Endocrinology and Metabolism 2006; submitted, Endocrinology and Metabolism, 2006
  • Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY: Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months revers bone loss and enhances trabecular and cortical bone strength: Calcif Tissue Int 79: 262-272, 2006., Calcif Tissue Int, 2006
  • Recker RR, Lappe J, Howard T, Wehren LE, Kimmel DB,: Effects of the menopause transition on cortical thickness of theilium: a paired biopsy study. Osteoporosis International 2006, S132:133., Osteoporosis International, 2006
  • Yang,T-L, Zhao L-J, LiuY-J, Recker RR, Deng H-W: Genetic and environmental correlations of bone mineral density at different skeletal sites in females and males: Calcif Tissue Int 78:212-217, 2006., Calcif Tissue Int, 2006
  • Zhao L-J, Liu P-Y, Recker R, Deng H-W:Correlation of transmenopoausal bone mass in healthy white women: a long-term longitudinal study: Submitted : 2006., Neurosurgery Clinics North America, 2006
  • Haynatzki GR, Haynatzka VR, Brand RE, Sherman S, Lynch HT, Recker RR: Comparison of statistical approaches for renetic anticipation with application to pancreatic cancer: Submitted, 2006., Neurosurgery Clinics North America, 2006
  • Robinson JA, Chatterjee-Kishore M, Yaworsky PJ, Cullen DM, Zhao W, Li C, Kharode Y, Lauter L, Babij P, Brown EL, Akhter MP, Johnson ML, Recker RR, Komm BS, Bex, FJ: Submitted 2006., Not Applicable, 2006
  • Barger-Lus MJ, Recker RR: Calcium, vitamin D, and fractures in the WHI data: BoneKEy Osteovision: 2006., BoneKEy-Osteovision, 2006
  • Xiao P, Zhao j, Guo Y, Liu YJ, Pei,YF, Shen H, Zhao LJ, Xiong DH, Papasian CJ, Drees BM, Hamilton JJ, Deng HY, Recker RR, Deng HW: Bivariate genome linkage analysis suggested pleiotropic effects on chromosomes 20p and 3p for body fat mass and lean mass: Int J Obes, 2007, under review., International J of Obesity, 2006
  • Tang ZH, Xiao P, Lei SF, Zhao LJ, Deng FY, Deng HY, Tan LJ, Shen H, Xiong DH, Recker RR, Deng HW: A bivariate who-genome linkage san suggests several shared genomic regions for obesity and osteoporosis: J Clin Endocrinol Metab, 2007. (under revision)., J Clin Endocrinol Metab, 2006
  • Zhang F, Xiong DH, Wang W, Shen J, Xiao P, Yang F, Recker RR, Deng HW: HDC gene polymorphisms are associated with age at natural menopause in Caucasian women: Biochem Biosphys Res Commun, 348: 1378-1382, 2007, Biochem. Biophys. Res. Commun., 2006
  • Guo YF, Shen H, Liu YJ, Wang W, Xiong DH, Xiao P, Liu YZ, Zhao LJ, Recker RR, Deng HW: Assessment of genetic linkage and parent-of-origin effects on obesity: J Clin endocrinol Metab, 91:4001-4005, 2006., J Clin Endocrinol Metab, 2006
  • Shen H, Long JR, Xiong DHm Guo YF, Xiao P, Liu YZ, Zhao LJ, Liu YJ, Deng HY, Li JL, Recker RR, Deng HW: A genomewide scan for quantitative trait loci underlying areal bone size variation in 451 Caucasion families: J Med Genet 43: 873-880, 2006., J Med Genet, 2006
  • Guo YF, Xiong DH, Shen H, Zhao LJ, Xiao P, Guo Y, Want W, Yang TL, Recker RR, Deng HW: Polymorphisms of the low-density kipiprotein receptor-related protein 5 (LRP5) genes are associated with obesity photypes in a large family-based association study: J Med Genet 43: 798-803, 2006., J Med Genet, 2006
  • Xiong DH, Shen H, Xiao P, Guo YF, Long JR, Zhao LJ, Liu YZ, Deng HY, Li JL, Recker RR, Deng HW: Genome-wide scan identified QTLs underlying femoral neck cross-sectional geometry that are novel studied risk factors of osteoporosis: J Bone Miner Res 21: 242-437, 2006., Journal of Bone and Mineral Research, 2006
  • Liu YZ, Xiao P, Guo YF, Xiong DH, Zhao LJ, Shen H, Liu YJ, Dvornyk,V, Long JR, Deng HY, Li JL, Recker RR, Deng HW: Genetic linkage of human height is confirmed to 9q22 and Xq24: Hum Genet 119: 295-304, 2006., Human Genetics, 2006
  • Xiao P, Liu P, Weber JL, Papasian CJ, Recker RR, Deng HW: Paternal uniparental isodisomy of the entire chromosome 3 revealed in a person with no apparent phenotypic disorders: Hum Mutat, 27: 133-137, 2006., Hum Mutat, 2006
  • Guo Y, Shen H, Xiao P, Xiong DH, Yang TL, Guo YF, Long JR, Recker RR, Deng HW: Genomewide linkage scan for quantitative trait loci underlying variation in age at menarche: J Clin Endocrinol Metab, 91:1009-1014, 2006., J. Clin Endo. and Metab., 2006
  • Lopez Franco GE, Blank R, McGuckin BL, Johnson ML, Cullen DM, Recker RR, Akhter MP: LRP5 regulation of intrinsic material properties of cortical bone. J Bone Miner Res 2005;M050:S325-326., J. Bone Miner. Res., 2005
  • Liu YJ, Recker RR, Deng HW: Genetics of obesity: current understanding and future prospects. In Body Mass Index: New Research, Chap VII, pp. 141-165, Nova Science Publishers Inc. 2005., Not Applicable, 2005
  • Miller PD, McClung MR, Macovei L, Stakkestad JA, Luckey M, Bonvoisin B, Reginster JY, Recker RR, Hughes C, Lewiecki EM, Felsenberg D, Delmas PD, Kendler DL, Bolognese MA, Mairon N, Cooper C: Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study. J Bone Miner Res 20:1315-1322, 2005., J. Bone Miner. Res., 2005
  • , Not Applicable, 2005
  • Recker RR, Barger-Lux MJ: Bone Biopsy and Histomorphometry in Clinical Practice:ASBMR:2005, Not Applicable, 2005
  • Long JR, Xu H, Zhao LJ, Liu PY, Shen H, Liu YJ, Xiong DH, Xiao P, Liu YZ, Dvornyk V, LI JL, Recker RR, Deng HW: The Oestrogen receptor alpha gene is linked and/or associated with age of menarche in different ethnic groups: J Med Genet, 42: 796-800, 2005., J Med Genet, 2005
  • Liu YJ, Xiao P, Xiong DH, Recker RR, Deng HW: Searching for obesity genes: progress and prospects: Drugs Today, 41: 345-362, 2005., Drugs Today, 2005
  • Zhao LJ, Liu PY, Long JR, Lu Y, Xu FH, Zhang YY, Shen H, Xiao P, Elze L, Recker RR, Deng HW: Test of linkage and/or association between the estrogen receptor alpha gene with bone mineral density in Caucasian nuclear families: Bone, 35: 395-402, 2004., Bone, 2005
  • Dvornyk V, Long JR, Xiong DH, Liu PY, Zhao LJ, Shen H, Zhang YY, Liu YJ, Rocha-Sanchez S, Xiao P, Recker RR, Deng HW: Current limitations of SNP data from the public domain for studies of complex disorders: a test for ten candidate genes for obesity and osteoporosis: BMC Genet, 5:4, 2004., Not Applicable, 2005
  • Liu YZ, Dvornyk V, Lu Y, Shen H, Lappe JM, Recker RR, Deng HW: A novel pathophysiological mechanism for osteoporosis suggested by an in vivo gene expression study of circulating monocytes. J Biol Chem Online June 17, 2005., J Biol Chem, 2005
  • Reginster JY, Felsenberg D, Cooper C, Stakkestad JA, Miller PD, Kendler DL, Adami S, McClung MR, Bolognese MA, Civitelli R, Dumont E, Bonvoisin B, Recker RR, Delmas PD: A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing ibandronate. Osteoporos Int Online June 14, 2005., Osteoporosis International, 2005
  • Recker RR, Gallagher R, MacCosbe PE. Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc 80:856-861, 2005., Mayo Clin Proc, 2005
  • Xiao P, Liu P, Lu Y, Guo Y, Xiong D, Li L, Recker RR, Deng HW. Association tests of interleukin-6 and type II tumor necrosis factor receptor (TNFR2) genes with bone mineral density in Caucasians using a re-sampling approach. Hum Genet Online May 20, 2005., J Med Genet, 2005
  • Recker RR: Current trends in osteoporosis. Supplement to Managed Care 14:3-8, 2005., Managed Care, 2005
  • Liu PY, Zhang YY, Lu Y, Long, JR, Shen H, Zhao LJ, Xu FH, Xiao P, Xiong DH, Liu YJ, Recker RR, Deng HW. A survey of haplotype variants at several disease candidate genes: the importance of rare variants for complex diseases. J Med Genet 42:221-227, 2005., J Med Genet, 2005
  • Murphy MG, Cerchio K, Stoch SA, Gottesdiener K, Wu M, Recker R. Effect of L-000845704, and ávâ3 integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. J Clin Endocrinol Metab 90:2022-2028, 2005., J Clin Endocrinol Metab, 2005
  • Chesnut CH, Ettinger MP, Miller PD, Baylink DJ, Emkey R, Harris ST, Wasnich RD, Watts NB, Schimmer RC, Recker RR. Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE. Curr Med Res Opin 21: 391-401, 2005., Current Medical Research and Opinion, 2005
  • Shen H, Liu Y, Liu P, Recker RR, Deng HW. Nonreplication in genetic studies of complex diseases – lessons learned from studies of osteoporosis and tentative remedies. J Bone Miner Res 20:365-376, 2005., J. Bone Miner. Res., 2005
  • Lappe J, Davies K, Recker R, Heaney R. Quantitative ultrasound: use in screening for susceptibility to stress fractures in female army recruits. J Bone Miner Res 20:571-578, 2005., J. Bone Miner. Res., 2005
  • Khalil DA, Lucas EA, Smith BJ, Soung DY, Devareddy L, Juma S, Akhter MP, Recker R, Arjmandi BH. Soy isoflavones may protect against orchidectomy-induced bone loss in aged male rats. Calcif Tissue Int 76:56-62, 2005., Calcif Tissue Int, 2005
  • Xiong DH, Xu FH, Liu PY, Shen H, Long JR, Elze L, Recker RR, Deng HW. Vitamin D receptor gene is linked and associated with adult height. J Med Genet 42:228-234, 2005., J Human Genetics, 2005
  • Recker R, Masarachia P, Santora A, Howard T, Chavassieux P, Arlot M, Rodan G, Wehren L, Kimmel D. Trabecular bone microarchitecture after alendronate treatment of osteoporotic women. Curr Med Res Opin 21:185-194, 2005., Current Medical Research and Opinion, 2005
  • Recker R, Lappe J, Davies KM, Heaney R. Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients. J Bone Miner Res 19:1628-1633, 2004., Journal of Bone and Mineral Research, 2004
  • Shen H, Zhang YY, Long JR, Xu FH, Liu YZ, Xiao P, Zhao LJ, Xiong DH, Liu YJ, Dvornyk V, Araujo S, Liu PY, Li JL, Conway T, Davies KM, Recker RR, Deng HW: A genome-wide linkage scan for bone mineral density in an extended sample: evidence for linkage on 11q23 and Xq27. J Med Genet 41:743-751, 2004., J Med Genet, 2004
  • Shen H, Zhang YY, Long JR, Xu FH, Liu YZ, Xiao P, Zhao LJ, Xiong DH, Liu YJ, Dvornyk V, Araujo S, Liu PY, Li JL, Conway T, Davies KM, Recker RR, Deng HW: A genome-wide linkage scan for bone mineral density in an extended sample: evidence for linkage on 11q23 and Xq27. J Med Genet 41:743-751, 2004., J Med Genet, 2004
  • Xu FH, Liu YJ, Deng H, Huang QY, Zhao LJ, Shen H, Liu YZ, Dvornyk V, Conway T, Li JL, Davies KM, Recker RR, Deng HW. Follow-up linkage study for bone size variation in an extended sample. Bone 35:777-784, 2004., Bone, 2004
  • Liu YZ, Xu FH, Shen H, Liu YJ, Zhao LJ, Long JR, Zhang YY, Xiao P, Xiong DH, Dvornyk V, Li JL, Conway T, Davies KM, Recker RR, Deng HW. Genetic dissection of human stature in a large sample of multiplex pedigrees. Ann Hum Genet 68:472-488, 2004., Ann Hum Genet, 2004
  • Barger-Lux MJ, Recker RR: The diagnosis of osteoporosis in postmenopausal women. In: Liu Y, ed., Current Topics in Osteoporosis, Chap. 6, World Scientific Publishing Company, 2004., Not Applicable, 2004
  • Recker RR, Barger-Lux MJ: The elusive concept of bone quality. Current Osteoporosis Reports 2:97-100, 2004., Current Osteoporosis Reports, 2004
  • Zhao LJ, Liu PY, Long JR, Lu Y, Xu FH, Zhang YY, Shen H, Xiao P, Elze L, Recker RR, Deng HW: Test of linkage and/or association between the estrogen receptor á gene with bone mineral density in Caucasian nuclear families. Bone 35:395-402, 2004., Bone, 2004
  • Huang QY, Xu FH, Shen H, Zhao LJ, Deng HY, Liu YJ, Dvornyk V, Conway T, Davies KM, Li JL, Liu YZ, Recker RR, Deng HW: A second-stage genome scan for QTLs influencing BMD variation. Calcif Tissue Int 75:138-143, 2004., Calcif Tissue Int, 2004
  • Akhter MP, Wells DJ, Short SJ, Cullen DM, Johnson ML, Haynatzki GR, Babij P, Allen KM, Yaworsky PJ, Bex F, Recker RR: Bone biomechanical properties in LRP5 mutant mice. Bone 35:162-169, 2004., Bone, 2004
  • Recker R, Stakkestad JA, Chesnut III CH, Christiansen C, Skag A, Hoiseth A, Ettinger M, Mahoney P, Schimmer RC, Delmas PD: Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis. Bone 34:890-899, 2004., Bone, 2004
  • Liu PY, Zin YJ, Zhou Q, Recker RR, Deng HW: Evidence for a major gene underlying bone size variation in Chinese. Am J Hum Biol 16:68-77, 2004., American Journal of Human Biology, 2004
  • Huang QY, Xu FH, Shen H, Deng HY, Conway T, Liu YJ, Liu JZ, Li JL, Li MX, Davies KM, Recker RR, Deng HW: Genome scan for QTLs underlying bone size variation at 10 skeletal sites: genetic heterogeneity and the significance of phenotype refinement. Physiol Genomics 17:326-331, 2004., Physiological Genomics, 2004
  • Liu YJ, Rocha-Sanchez SMS, Liu PY, Long JR, Lu Y, Elze L, Recker RR, Deng HW: Tests of linkage and/or association of the LEPR gene polymorphisms with obesity phenotypes in Caucasian nuclear families. Physiol Genomics 17:101-106, 2004., Physiological Genomics, 2004
  • Dvornyk V, Long JR, Xiong DH, Liu PY, Zhao LJ, Shen H, Zhang YY, Liu YJ, Rocha-Sanchez S, Xiao P, Recker RR, Deng HW: Current limitations of SNP data from the public domain for studies of complex disorders: a test for ten candidate genes for obesity and osteoporosis. BMC Genetics 5:4, 2004., BMC Genetics, 2004
  • Recker RR: Genetic research in osteoporosis: Where are we? Where should we go next? J Musculoskel Neuron Interact 4:86-90, 2004., J Musculoskel Neuron Interact, 2004
  • Deng HW, Recker RR: Gene mapping and identification for osteoporosis. J Musculoskel Neuron Interact 4:91-100, 2004., J Musculoskel Neuron Interact, 2004
  • Liu YJ, Xu FH, Shen H, Liu YZ, Deng HY, Zhao LJ, Huang QY, Dvornyk V, Conway T, Davies KM, Li JL, Recker RR, Deng HW : A follow-up linkage study for quantitative trait loci contributing to obesity-related phenotypes. J Clin Endocrinol Metab 89 :875-882, 2004., J Clin Endocrinol Metab, 2004
  • Dvornyk V, Shen H, Liu YJ, Xiao P, Recker RR, Deng HW: Systematic approach to the study of complex bone disorders at the whole-genome level. Current Genomics 5:93-109, 2004., Current Genomics, 2004
  • McClung MR, Wasnich RD, Recker R, Cauley JA, Chesnut III CH, Ensrud KE, Burdeska A, Mills T, for the Oral Ibandronate Study Group: Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis. J Bone Miner Res 19:11-18, 2004., Journal of Bone and Mineral Research, 2004
  • Rubin C, Recker R, Cullen D, Ryaby J, McCabe J, McLeod K: Prevention of postmenopausal bone loss by a low-magnitude, high-frequency mechanical stimuli; a clinical trial assessing compliance, efficacy and safety. J Bone Miner Res 19:343-351, 2004., Journal of Bone and Mineral Research, 2004
  • Recker RR, Weinstein RS, Chesnut III CH, Schimmer RC, Mahoney P, Hughes C, Bonvoisin B, Meunier PJ: Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study. Osteoporos Int 15:231-237, 2004., Osteoporosis International, 2004
  • Livshits G, Deng HW, Nguyen TV, Yakovenko K, Recker RR, Eisman JA: Genetics of bone mineral density: Evidence for a major pleiotropic effect from an intercontinental study. J Bone Miner Res 19:914-923, 2004., Journal of Bone and Mineral Research, 2004
  • Akhter MP, Otero JK, Iwaniec UT, Cullen DM, Haynatzki GR, Recker RR: Differences in vertebral structure and strength of inbred female mouse strains. J Musculoskel Neuron Interact 4:33-40, 2004., J Musculoskel Neuron Interact, 2004
  • Recker RR: Transmenopausal and age-related changes in bone remodeling. J Musculoskel Neuron Interact 3 :411-412, 2003., J Musculoskel Neuron Interact, 2003
  • Huang QY, Recker RR, Deng HW: Searching for osteoporosis genes in the post-genome era: progress and challenges. Osteoporos Int 14:701-715, 2003., Osteoporosis International, 2003
  • Paschalis EP, Recker R, Dicarlo E, Doty SB, Atti E, Boskey AL: Distribution of collagen cross-links in normal human trabecular bone. J Bone Miner Res 18:1942-1946, 2003., Journal of Bone and Mineral Research, 2003
  • Xiong DH, Long JR, Recker RR, Deng HW: Pharmacogenomic approaches to osteoporosis. Pharmacogenomics J 3:261-263, 2003., Pharmacogenomics, 2003
  • Shen H, Recker RR, Deng HW: Molecular and genetic mechanisms of osteoporosis: implication for treatments. Current Molecular Medicine 3:737-757, 2003., Current Molecular Medicine, 2003
  • Liu YZ, Liu YJ, Recker RR, Deng HW: Molecular studies of gene identification for osteoporosis: the 2002 update. J of Endocrinology 177:147-196; 2003., Journal of Endocrinology, 2003
  • Akhter MP, Iwaniec UT, Haynatzki GR, Fung YK, Cullen DM, and Recker RR: Effects of nicotine on bone mass and strength in aged female rats. J Orth Res 21:14-19,2003., Journal of Orthopaedic Research, 21, 14-19, 2003
  • Smith SY, Recker RR, Hannan M, Muller R, Bauss F: Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys. Bone 32:45-55,2003., Bone, 32, 45-55, 2003
  • Lei SF, Deng FY, Liu XH, Huang QR, Qin Y, Zhou Q, Jiang DK, Li YM, Mo XY, Liu MY, Chen XD, Wu XS, Shen H, Dvornyk V, Zhao L, Recker RR, Deng HW: Polymorphisms of four bone mineral density candidate genes in Chinese populations and comparison with other populations of different ethnicity. J Bone Miner Res 21:34-42; 2003., Journal of Bone and Mineral Research, 21, 34-42, 2003
  • Recker RR: Osteoporosis Trials: Ethics in Study Design; Proceedings of Two Conferences. J Bone Miner Res 18:1116; 2003., Journal of Bone and Mineral Research, 18, 1116, 2003
  • Dvornyk V, Recker RR, Deng HW: Gene expression studies of osteoporosis: implications for microarray research. Osteoporos Int 14:451-461; 2003., Osteoporosis International, 14, 451-461, 2003
  • Qin YJ, Shen H, Huang QR, Zhao LJ, Zhou Q, Li MX, He JW, Mo XY, Lu JH, Recker RR, Deng HW: Estrogen receptor a gene polymorphisms and peak bone density in Chinese nuclear families. J Bone Miner Res 18:1028-1035; 2003., Journal of Bone and Mineral Research, 18, 1028-1035, 2003
  • Liu YJ, Araujo S, Recker RR, Deng HW: Molecular and genetic mechanisms of obesity: implications for future management. Current Molecular Medicine 3:325-340; 2003., Current Molecular Medicine, 3, 325-340, 2003
  • Deng HW, Xu F-H, Davies KM, Heaney RP, Recker RR: Differences in bone mineral density, bone mineral content, and bone areal size in fracturing and non-fracturing women, and their interrelationships at the spine and hip. J Bone Miner Metab 20:358-366, 2002., Journal of Bone & Mineral Metabolism, 20, 358-366, 2002
  • Delmas PD, Ensrud KE, Adachi JD, Harper KD, Sarkar S, Gennari C, Reginster JY, Pols HAP, Recker RR, Harris ST, Wu W, Genant HK, Black DM, Eastell R: Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoprosis: 4-year results from a randomized clinical trial. J Clin Endocrinol Metab 87:3609-3617,2002., Journal of Clinical Endocrinology and Metabolism, 87, 3609-3617, 2002
  • Deng HW, Livshits G, Yakovenko K, Xu FH, Conway T, Davies KM, Deng H, Recker RR: Evidence for a major gene for bone mineral density/content in human pedigrees identified via probands with extreme bone mineral density. Ann Hum Genet, 66:61-64; 2002., Annals of Human Genetics, 66, 61-64, 2002
  • Deng HW, Shen H, Xu FH, Deng HY, Conway T, Zhang HT, Recker RR: Tests of linkage and/or association of genes for vitamin D receptor, osteocalcin, and parathyroid hormone with bone mineral density. J Bone Miner Res, 17:678-688; 2002., Journal of Bone Mineral Research, 17, 678-688, 2002
  • Deng HW, Mahaney MC, Williams J, Li J, Conway T, Davies KM, Li JL, Deng HY, Lai DB, and Recker RR: Relevance of the genes for Bone Mass Variation to Susceptibility to Osteoporotic Fractures and its implications to gene search for complex human diseases. Genet Epidemiol 22:12-25,2002., Genetic Epidemiology, 22, 12-25, 2002
  • Deng HW, Deng XT, Conway T, Xu FH, Heaney RP, Recker RR: Determination of bone size of hip, spine, and wrist in human pedigrees by genetic and lifestyle factors, J Clin Densit 5(1):45-56, Spring 2002., Journal of Clinical Densitometry, 5, 45-56, 2002
  • Akhter MP, Cullen DM, Recker RR: Bone adaptation response to sham and bending stimuli in mice. J Clin Densit 5:207-216; 2002., Journal of Clinical Densitometry, 5, 207-216, 2002
  • Deng HW, Xu FH, Liu YZ, Shen H, Deng H, Huang QY, Liu YJ, Conway T, Li JL, Davies KM, Recker RR: A whole genome linkage scan suggests several genomic regions potentially containing QTLs underlying the variation of stature. Am J Med Genet 113:29-39; 2002., American Journal of Medical Genetics, 113, 29-39, 2002
  • Deng HW, Xu FH, Huang QY, Shen H, Deng HY, Conway T,Liu YJ, Liu YZ, Zhang HT, Davies KM, Recker RR: A whole genome scan suggests several genomic regions potentially containing quantitative trait loci for osteoporosis. Journal of Clinical Endocrinology and Metabolism 87: 5151-5159; 2002., Journal of Clinical Endocrinology and Metabolism, 87, 5151-5159, 2002
  • Deng HW, Chen WM, Recker RR: Transmission disequilibrium test with discordant sib pairs when parents are available. Hum Genet, 110:451-461; 2002., Human Genetics, 110, 451-461, 2002
  • Barger-Lux MJ, Recker RR: Bone microstucture in osteoporosis: transilial biopsy and histomorphometry. Topics in Magnetic Resonance Imaging, 13:297-306; 2002., Topics in Magnetic Resonance Imaging, 13, 297-306, 2002
  • Deng HW, Recker RR: On Genetics and Gene mapping approaches and status for osteoporosis research. Proceedings of International Symposium on mapping and identification of genes for complex traits. Edited by HW Deng, DZ Ying, and XS Wu, HuNan Publishing House for Science and Technology, 2002., Not Applicable, 2002
  • Recker RR, Barger-Lux MJ: Osteoporosis: etiology, diagnosis and treatment. In Orthopaedics, Chap. 8, pp. 201-207. Robert Fitzgerald, Herbert Kaufer, Arthur L. Malkani, eds. Mosby, Inc. 2002., Not Applicable, 2002
  • Recker RR, Barger-Lux MJ: Embryology, anatomy, and microstructure of bone. In Coe FL, and Favus MJ, eds. Disorders of Bone and Mineral Metabolism, 2nd edition. Philadelphia, Lippincott Williams and Wilkins, 2002., Not Applicable, 2002
  • Recker RR and Deng HW . The role of genetics in osteoporosis., Endocrine, 17(1), 55-66, 2002
  • Little RD, Carulli J, Del Mastro RG, Dupuis J, Osborne M, Root C, Manning S, Swain P, Zhao S-C, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, Fitzgerald M, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, Mcguire S, Nogues X, Gong G, Allen KM, Anisowicz A, Lomedico PT, Recker SM,Van Eerdewegh P, Recker RR, Johnson M. A single amino acid change in causes the high bone mass trait linked to 11q13., American Journal of Human Genetics, 70, 11-19, 2002
  • Deng HW, Li J, Mahaney MC, Conway T, Davies KM, Williams JT, Li JL, Deng H, Lai DB, Recker RR. Relevance of the genes for bone mass variation to susceptibility to osteoporotic fractures and its implications to gene search for complex human diseases., Genetic Epidemiology, 22, 12-25, 2002
  • Deng HW, Chen, WM, Recker, R R Powerful and robust tests of linkage and association based on parental genotypes to map genes underlying complex traits. Life Science Research (China in English), Life Science Research, 2002
  • Deng HW, Mahaney MC, Williams J, Li J, Conway T, Davies KM, Li JL, Deng HY, Lai DB, and Recker RR. Relevance of the genes for Bone Mass Variation to Susceptibility to Osteoporotic Fractures and its implications to gene search for complex human diseases., Genetic Epidemiology, 22, 12-25, 2002
  • Recker,RR. Osteoporosis in women., J Musculoskel Neuron Interact, 3, 1, 2002
  • Huang QY, Xu FH, Shen H, Deng HY, Liu YJ, Liu YZ, Li JL, Recker RR, Deng HW. Mutation patterns at dinucleotide microsatellite loci in humans,, American Journal of Clnical Nutrition, 70, 625-634, 2002
  • Deng HW, Deng HY, Liu YJ, Liu YZ, Xu FH, Shen H, Conway T, Li JL, Huang QY, Davies KM, Recker RR. A genomewide linkage scanfor quantitative-trait loci for obesity phenotypes, American Journal of Clnical Nutrition, 70, 1138-1151, 2002
  • Deng HW, Deng XT, Conway T, Xu FH, Heaney RP, Recker RR. Determination of bone size of hip, spine, and wrist in human pedigrees by genetic and lifestyle factors, J Clinical Densitometry, 5(1), 45-56, 2002
  • Akhter MP, Cullen DM, Recker RR. Breed related bone response to in vivo sham and bending loads., J Clinical Densitometry, 2002
  • Liu YZ, Liu YJ, Recker RR, Deng HW. Molecular studies of gene identification for osteoporosis: the 2002 update., Journal of Clinical Endocrinology and Metabolism, 2002
  • Huang QY, Xu FH, Shen H, Deng HY, Liu YJ, Liu YZ, Li JL, Recker RR, Deng HW. Mutation patterns at dinucleotide microsatellite loci in humans, Am J Clin Nutr 70:625-634, 2002., American Journal of Clnical Nutrition, 70, 625-634, 2002
  • Recker RR, Barger-Lux MJ. Osteoporosis: etiology, diagnosis and treatment. In Orthopaedics, Chap. 8, pp. 201-207. Robert Fitzgerald, Herbert Kaufer, Arthur L. Malkani, eds. Mosby, Inc. 2002., Not Applicable, 2002
  • Recker RR, Barger-Lux MJ. Embryology, anatomy, and microstructure of bone. In Coe FL, and Favus MJ, eds. Disorders of Bone and Mineral Metabolism, 2nd edition. Philadelphia, Lippincott Williams and Wilkins, 2002., Not Applicable, 2002
  • Gong G, Recker RR,Deng H-W. Mapping disease with Lewontin's linkage disequilibrium measure, Life Science Research, 5, 1-8, 2001
  • Recker RR, Heaney RP. Editorial: The role of combination treatment for osteoporosis, Journal of Clinical Endocrinology and Metabolism, 86, 1888-1889, 2001
  • Samnegard E, Akhter MP, Recker RR. Maintenance of vertebral body bone mass and strength created by hPTH treatment in ovariectomized rats, Bone, 28, 414-422, 2001
  • Davies KM, Heaney RP, Recker RR, Barger-Lux MJ, Lappe JM. Hormones, weight change and menopause, International J of Obesity, 874-879, 2001
  • Akhter MP, Kimmel DB, Recker RR. Effect of parathyroid hormone (hPTH[1-84] treatment on bone mass and strength in ovariectomized rats, Journal of Clinical Densitometry, 4, 13-23, 2001
  • Samnegard E, Iwaniec UT, Cullen DM, Kimmel DB, Recker RR. Maintenance of cortical bone in human parathyroid hormone (1-84)-treated ovariectomized rats, Bone, 28, 251-260, 2001
  • Sarno M, Sarno L, Baylink D, Drinkwater B, Farley S, Kleerekper M, Lang R, Lappe J, Licata A, McClung M, Miller P, Nattrass S, Recker RR, Schwartz EN, Tucci JR, Wolf S, Powell H, Tjersland G, Warnick GR. Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone disease, Clin Chem Lab Med, 39, 223-228, 2001
  • Samnegard E, Akhter MP, Recker RR. Maintenance of vertebral body bone mass and strength created by human parathyroid hormone treatment in ovarienctomized rats, Bone, 28(4), 414-422, 2001
  • Deng HW, Li J, Recker RR. LOD score exclusion analyses for candidate genes using random population samples, Ann Hum Genet, 65, 313-329, 2001
  • Gong GD, Recker RR and Deng HW. Fine mapping with Lewontin's linkage disequilibrium measure., Life Science Research, 5, 1-8, 2001
  • Deng HW, Li J, Recker RR. LOD score exclusion analyses of candidate genes with random population samples., Ann Hum Genet, 65, 313-329, 2001
  • Deng HW, Xu FH, Conway T, Deng XT, Li JL, Davies KM, Deng HY, Johnson M L and Recker RR. Is population bone mineral density variation linked to the marker D11S987 on chromosome 11q12-13? J Clin Endocrinol & Metab 86:3735-3741, 2001., Journal of Clinical Endocrinology and Metabolism, 86, 3735-3741, 2001
  • Lappe JM, Stegman MR, Recker RR. The impact of lifestyle factors on stress fractures in female army recruits., Osteoporosis International, 12, 35-42, 2001
  • Samnegard E, Akhter MP, Recker RR. Maintenance of vertebral body bone mass and strength created by hPTH treatment in ovariectomized rats., Bone, 28, 414-422, 2001
  • Davies KM, Heaney RP, Recker RR, Barger-Lux MJ, Lappe JM. Hormones, Weight Change, and Menopause., International J of Obesity, 874-879, 2001
  • Akhter MP, Cullen DM, Gong G, Recker RR. Bone biomechanical properties in prostaglandin EP1 and EP2 knock-out mice., Bone, 29, 121-125, 2001
  • Lappe JM, Stegman MR, Davies KM, Barber S, Recker RR. A prospective study of quantitative ultrasound in children and adolescents., J Clinical Densitometry, 3, 167-175, 2001
  • Lai DB, Recker RR, Li J, Conway T, Xu FH, Deng XT, Deng HW. Characterization of genetic and life-style factors for determining variation of BMI, fat mass, percentage fat mass and lean mass., J Clinical Densitometry, 4, 353-361, 2001
  • Gong G, Recker RR, Deng H-W. Mapping disease with Lewontin’s linkage disequilibrium measure., Life Science Research, 5, 1-8, 2001
  • Akhter M, Kimmel DB, Recker RR. Effect of Parathyroid Hormone (hPTH[1-84]) Treatment on Bone Mass and Strength in Ovariectomized Rats., J Clinical Densitometry, 4, 13-23, 2001
  • Samnegard E, Iwaniec UT, Cullen DM, Kimmel DB, Recker RR. Maintenance of cortical bone in human parathyroid hormone (1-84)-treated ovariectomized rats., Bone, 28, 251-260, 2001
  • Sarno M, Sarno L, Baylink D, Drinkwater B, Farley S, Kleerekoper M, Lang R, Lappe J, Licata A, McClung M, Miller P, Nattrass S, Recker RR, Schwartz EN, Tucci JR,Wolf S, Powell H, Tjersland G, Warnick GR. Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone disease., Clin Chem Lab Med, 39, 223-228, 2001
  • Deng HW, Chen WM, Recker RR. Population admixture: detection by Hardy-Weinberg test and its quantitative effects on linkage-disequilibrium methods for localizing genes underlying complex traits., Genetics, 157, 885-897, 2001
  • Samnegard E, Akhter MP, Recker RR. Maintenance of vertebral body bone mass and strength created by human parathyroid hormone treatment in ovariectomized rats., Bone, 28, 414-422, 2001
  • Deng HW, Li J, Recker RR. Effect of polygenes on Xiong’s transmission disequilibrium test of a QTL in nuclear families with multiple children., Genetic Epidemiology, 21, 243-265, 2001
  • Li JL, Deng H, Lai DB, Xu F, Chen J, Gao G, Recker RR, Deng HW. Toward high-throughput genotyping: dynamic and automatic software for manipulating large-scale genotype data using fluorescently labeled dinucleotide markers., Genome Research, 11, 1304-1314, 2001
  • Deng HW, Li J, Recker RR. LOD score exclusion analyses for candidate genes using random population samples., Ann Hum Genet, 65, 313-329, 2001
  • Lappe JM, Stegman MR, Recker RR. The impact of lifestyle factors on stress fractures in female army recruits, Not Applicable, 12, 2001
  • Deng H-W, Lai DB, Li J, Conway T, Xu FH, Davies KM, Recker RR. Characterization of genetic and life-style factors for determining variation of BMI, fat mass, Percentage fat mass, and lean mass. J Clin Densit 4:353-361, Winter 2001., J Clinical Densitometry, 4, 353-361, 2001
  • Emkey R, Recker R, Stakkestad JA, Schimmer R, Mahoney P. Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from a large phase III study. Submitted, May 2002.
  • Deng H-W, Xu F-H, Davies KM, Heaney RP, Recker RR. Bone mineral density, bone mineral content and bone size in fracturing and non-fracturing females and their different relationship at the spine and hip. Submitted, 2001.
  • Akhter MP, Iwaniec UT, Haynatzki GR, Fung YK, Cullen DM, and Recker RR Effects of Nicotine on Bone Mass and Strength in Aged Female Rats. J Orth Res, Submitted 2001.
  • Smith SY, Recker RR, Hannan M, Muller R, Bauss F. Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys. Submitted, 2001.
  • Delmas PD, Ensrud KE, Adachi JD, Harper KD, Sarkar S, Gennari C, Reginster J-Y, Pols HAP, Recker RR, Harris ST, Wu W, Genant HK, Black DM, Eastell R. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoprosis: 4-year results from a randomized clinical trial. Submitted, 2001.
  • Deng H-W, Livshits G, Yakovenko K, Xu F-H, Conway T, Davies KM, Deng H, Recker RR. Evidence for a major gene for bone mineral density/content in human pedigrees identified via probands with extreme bone mineral density. Submitted, 2001.
  • Deng H-W, Zhang H-T, Shen H, Xu F-H, Li Y, Conway T, Recker RR. Tests of linkage and/or association of genes for vitamin D receptor, osteocalcin, and parathyroid hormone with bone mineral density (BMD). Submitted, 2001.
  • Deng HW, Shen H, Xu FH, Zhang HT, Deng HY, Conway T, Liu YJ, Liu YZ, Xia QH, Chen J, Huang QY, Davies KM, Recker RR. A whole-genome linkage scan suggests several genomic regions potentially containing QTLs for bone size variation. Submitted, 2001.
  • Deng HW, Xu FH, Shen H, Zhang HT, Deng HY, Conway T, Huang QY, Chen J, Xia QH, Liu YZ, Liu YJ, Davies KM, Recker RR. A whole-genome linkage scan suggests several genomic regions potentially containing QTLs for bone mineral density (BMD) variation. Submitted, 2001.
  • Deng, HW, Livhshits G, Xu FH, Conway T, Davies KM, Deng HY, Recker RR. Evidence of a major gene for bone mineral density/content in human pedigrees identified via probands with extreme bone mineral density. In Press, Ann Hum Genet, 2002.
  • Deng HW, Dent XT, Conway T, Xu FH, Davies KM, Li JL, Li J, Lai DB, Deng H, Johnson ML, Chen WM, Recker RR. Is population BMD variation linked to the marker D11S987 on chromosome 11q12-13? In Press, J Clin Endocrinol & Metab, 2002.
  • Deng, HW, Zhang HT, Shen H, Xu FH, Deng HY, Li Y, Conway T, Davies KM, Recker RR. Test of linkage and association of vitamin D receptor gene, osteocalcin gene, and parathyroid hormone gene to bone mineral density in Caucasian pedigrees. In Press, J Bone Miner Res, 2002.
  • Johnson ML, Picconi JL, Recker RR. The gene for high bone mass, Submitted, 2002.
  • Delmas PD, Ensrud KE, Adachi JD, Harper KD, Sarkar S, Gennari C, Reginster J-Y, Pols HAP, Recker RR, Harris ST, Wu W, Genant HK, Black DM, Eastell R. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis. 4-year results from a randomized clinical trial. Submitted, May 2002.
  • Deng HW, Xu FH, Davies KM, Heaney RP, Recker RR. Bone mineral density, bone mineral content and bone areal size differ in fracturing and non-fracturing females and their interrelationships differ at the spine and hip. Accepted, May 2002.
  • Brody BA, Dickey N, Ellenberg SS, Heaney RP, Levine RJ, Marcus R, O’Brien RL, Purtilo RB, Recker RR, Watts NB, Weijer C. Is the use of placebo controls ethically permissible in clinical trials of agents intended to reduce fractures in osteoporosis? Accepted, June 2002.
  • Deng HW, Dent XT, Conway T, Xu FH, Davies KM, Li JL, Li J, Lai DB, Deng H, Johnson ML, Chen WM, Recker RR: Is population BMD variation linked to the marker D11S987 on chromosome 11q12-13? In Press, J Clin Endocrinol & Metab, 2002.
  • Deng, HW, Zhang HT, Shen H, Xu FH, Deng HY, Li Y, Conway T, Davies KM, Recker RR: Test of linkage and association of vitamin D receptor gene, osteocalcin gene, and parathyroid hormone gene to bone mineral density in Caucasian pedigrees. In Press, J Bone Miner Res, 2002.
  • Akhter MP, Otero JK, Iwaniec UT, Cullen DM, Recker RR: Genetic variation in vertebral biomechanics and histomorphometry in mice. Submitted, 2002.
  • Johnson ML, Picconi JL, Recker RR: The gene for high bone mass, Submitted, 2002.
  • Emkey R, Recker R, Stakkestad JA, Schimmer R, Mahoney P: Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from a large phase III study. Submitted, May 2002.

Publications

  • Xiong D-H, Lei S-F, Yang F,Wang L, Peng Y-M, Wnag W, Recker RR, Deng H-W: Low-Density Lipoprotein Receptor-Related Protein 5 (LRP5) gene polymorphisms are associated with bone mass in both Chinese and Whites: J Bone Min Res:1007, J. Bone Miner. Res., 2007
  • Recker R, Czerwinski E, Felsenberg D, Hughes C, Bonvoisin B, Masanaukaite D, Ste-Marie LG: Bone safety of intermittent intravenous ibandronate injections: bone histomorphometry from the DIVA study. ASBMR 28th Annual Meeting 2006;1050:S15, ASBMR 28th Annual Meeting, 2006
  • Zhao L, Xiong D, Guo Y, Recker R, Deng H: Genetic effects are associated with increased risk of both osteoporosis and obesity: a study of RANK gene. ASBMR 28th Annual Meeting 2006;1288:S76, ASBMR 28th Annual Meeting, 2006
  • Ralston SH, Ionnidis J, Ng M, Sham P, Zintzaras E, Deng H, Michael EJ, Karasik D, Devoto M, Kammerer C, Spector T, Cupples A, Froud T, Kiel D, Koller DL, Bente L, Mitchell B, Peacock M, Recker R, Shen H, Sol-Church K, Spotila L, Uitterlinden AG, Wilson SG, Kung AWC: Collaborative genome search meta-analysis for bone mineral density. ASBMR 28th Annual Meeting 2006;F135:S88, ASBMR 28th Annual Meeting, 2006
  • Recker R, Eusebio R, Xu S, Boonen S: Oral risedronate treatment in men wiwth osteoporosis: effects on bone quality and bone remodeling. ASBMR 28th Annual Meeting 2006;F354:S110, ASBMR 28th Annual Meeting, 2006
  • Kendler D, Recker R, Lewiecki E, Cauley J, Binkley N, Olszynski W, Lorraine J, Qu Y, Wong M, Plouffe L, Stock J: Relationships between bone mineral density and breast cancer risk (by Gail model) in postmenopausal women with low bone mass or osteoporosis. ASBMR 28th Annual Meeting 2006;M081:S348, ASBMR 28th Annual Meeting, 2006
  • Akhter MP, Cullen DM, Recker RR: Tobacco smoking influences on bone mechanical properties. ASBMR 28th Annual Meeting 2006; SU088:S228, ASBMR 28th Annual Meeting, 2006
  • Recker RR, Boonen S, Garcia P, Supronik J, Peichl P, Black D, Krasnow J, Chiodo J, Gasser, J, Ericksen, E: The effect of annual treatment with zolendronic acid 5 mg on bone remodeling: bone histomophometry results from the HORIZON-PFT. ASBMR 28th Annual Meeting 2006;SU332:S290, ASBMR 28th Annual Meeting, 2006
  • Recker RR, Kriegman A, Adera M, Zhou W, Miller P: Bone histomorphometry demonstrates normal bone remodeling in postmenopausal women with low bone mineral density switched from oral alendronate to IV zolendronic acid. ASBMR 28th Annual Meeting 2006;SA357:S182, ASBMR 28th Annual Meeting, 2006
  • Recker R, Kriegman A, Adera M, Zhou W, Miller P,: Bone histomorphometry demonstrates normal bone remodeleing in postmenopausal women with low bone mineral density switched from oral alendronate to IV zoledronic acid. Arthrisis & Rheumatism 2006; submitted, Arthritis & Rheumatism, 2006
  • Ste-Marie L-G, Langdahl B, Felsenberg D, Czerwinski E, Hughes C, Bonboisin B, Masanauskaite D, Recker RR,: Intermittent intravenous ibandronate injections are associated with newly formed bone of normal quality: the DIVA study. Arthritis & Rheumatism 2005; submitted, Arthritis & Rheumatism, 2006
  • Miller PD, Ward P, Leigh C, Burdeska, Recker RR,: Intravenous ibandronate injections and oral ibandronate: favorable renal tolerability profile in postmenopausal osteoporosis. Arthritis and Rheumatism 2006; submitted, Arthritis & Rheumatism, 2006
  • Recker RR, Boonen S, Garcia P, Supronik J, Peichl D,Black D, Krasnow J, Chiodo J, Gasser J, Ericksen E,: The effect of annual treatment with zoledronic acid 5 mg on bone remodeling: bone histomorphometry results from the HORIZON-PFT. Arthritis & Rheumatism 2006; submitted, Arthritis & Rheumatism, 2006
  • Zhao LJ, Liu YJ, Hamilton J, Recker RR, Deng HW: Interventions decreasing obesity risk tend to be beneficial for decreasing risk to osteoporosis: a challenge to the current dogma. Osteoporosis International 2006; S161., Osteoporosis International, 2006
  • Zhao LJ, Liu YJ, Hamilton J, Recker RR, Deng HW: Interventions decreasing obesity risk tend to be beneficial for decreasing risk to osteoporosis: a challenge to the current dogma. Osteoporosis International 2006; S161., Osteoporosis International, 2006
  • Recker R, Resch H, Chen P, Misurski D, Pavo I, Sipos A,: Relationship between teriparatide-mediated changes in BMD and microarchitecture in postmenopausal women with osteoporosis. Osteoporosis International 2006; S211., Osteoporosis International, 2006
  • Binkley N, Lippuner K, Recker R, Bianchi G, Minisola S, Ljunggren O, Benevolenskaya L, Liu M, Lamotta A, Santora A,: The effect of a once-weekly tablet containing alendronate and vitamin D3 for the treatment of osteoporosis. Osteoporosis International 2006; S219, Osteoporosis International, 2006
  • Recker RR,: Options when oral dosing is unsuitable: intravenous bisphosphonates. Osteoporosis International 2006; S358., Osteoporosis International, 2006
  • Lappe JM, Travers-Gustafson D, Davies KM, Heaney RP, Recker RR: Vitamin D and calcium supplementation reduces cancer risk: Submitted 2006., Neurosurgery Clinics North America, 2006
  • Xiong DH, Shen H, Recker RR, Deng HW: Gene search for femoral neck cross-sectional geometry. J Bone Miner Res 2005;1211:S53., J. Bone Miner. Res., 2005
  • Akhter MP, McGuckin BL, Howard TD, Bare SP, Davies KM, Lappe JM, Recker RR: Trans-menopausal changes in the trabecular bone structure. J Bone Miner Res 2005;F358:S91., J. Bone Miner. Res., 2005
  • Bare S, Recker S, Recker R, Kimmel D: Influence of alendronate on periosteal and endocortical bone formation in the ilium of osteoporotic women. J Bone Miner Res 2005;F414:S96., J. Bone Miner. Res., 2005
  • Recker R, Kendler D, Recknor C, Rooney T, Lewiecki EM, Utian WH, Cauley J, Lorraine J, Qu Y, Kulkarni PM, Plouffe L, Stock JL: Effects of raloxifene or alendronate on fracture risk reduction: results from the EVA (Evista®/Alendronate comparison) trial. J Bone Miner Res 2005;F425:S97., J. Bone Miner. Res., 2005
  • McClung M, Siris E, Cummings S, Bone H, Recker R, Delmas P, Zanchetta J, Lewiecki M, Zerbini C, Miller S, Wolter K, Proulx J, Brunell R, Radecki D: Lasofoxifene increased BMD of the spine and hip and decreased bone turnover markers in postmenopausal women with low or normal BMD. J Bone Miner Res 2005;F429:S97., J. Bone Miner. Res., 2005
  • Dempster DW, Moreau LA, Varela A, Smith SY, Ste-Marie LG, Fox J, Newman MK, Recker RR: Treatment of postmenopausal osteoporotic women with parathyroid hormone 1-84 for 18 months improves trabecular bone architecture: a study of iliac crest biopsies using micro-computed tomography. J Bone Miner Res 2005;F435:S98., J. Bone Miner. Res., 2005
  • Xiao P, Guo YF, Recker RR, Deng HW: Genomic regions identified for BMD in an exceptionall large sample by considering epistasis. J Bone Miner Res 2005;SU179:S231., J. Bone Miner. Res., 2005
  • Bare S, Recker S, Recker R, Kimmel D: Bone formation in the periosteal, endocortical, and trabecular envelopes of the ilium of adult women. J Bone Miner Res 2005;SU368:S274., J. Bone Miner. Res., 2005
  • Masarachia PJ, Recker R, Santora A, Chavassieux P, Arlot M, Kimmel D. Effect of alendronate on cortical and trabecular bone of the transilial biopsy as measured by micro-CT. J Bone Miner Res 2005;SU393:S280., J. Bone Miner. Res., 2005
  • Civitelli R, Tanko LB, Vyskocil V, Leigh C, Ward P, Masanauskaite D, Recker RR: Renal tolerability of ibandronate when administered by intravenous injection: DIVA 1-year analysis. J Bone Miner Res 2005;SU412:S284-285., J. Bone Miner. Res., 2005
  • Emkey R, Halse J, Kruse HP, Hughes C, Ward P, Masanauskaite D, Recker RR: Consistent bone mineral density gains with intravenous ibandronate injections: results from the DIVA study. J Bone Miner Res 2005;SU413:S285., J. Bone Miner. Res., 2005
  • Zhao LJ, Liu YJ, Recker RR, Deng HW: Genes decrease osteoporosis risk also decrease risk of obesity. J Bone Miner Res 2005;M108:S339., J. Bone Miner. Res., 2005
  • Lappe JM, Travers-Gustafson D, Barger-Lux MJ, Davies KM, Heaney RP, Recker RR: Population-based evidence that serum 25(OH)D levels below 80nmol/L reflect vitamin D deficiency. J Bone Miner Res 2005;M279:S379., J. Bone Miner. Res., 2005
  • Recker RR, Luckey M, Stakkestad JA, Civitelli R, Hughes C, Mairon N, Bonvoisin B, Cooper C: Large proportions of women with postmenopausal osteoporosis respond to once-monthly oral ibandronate: 2-year results from MOBILE. J Bone Miner Res 2005;M346:S395., J. Bone Miner. Res., 2005
  • Lips PT, Recker RR, Rosen CJ, Bone H, Minne HW, Callahan G, Lamotta A, He W: The effect of a once-weekly tablet containing alendronate and vitamin D3 for the treatment of osteoporosis. J Bone Miner Res 2005;M353:S396-397., J. Bone Miner. Res., 2005
  • Recker RR: Alendronate effects on histomorphometric parameters: is there evidence for over-suppression of turnover? J Bone Miner Res 2005;M358:S398., J. Bone Miner. Res., 2005
  • Recker RR, Davies KM, Barger-Lux MJ: Treatment of postmenopausal osteoporosis with oral ibandronate reduces activation frequency to healthy premenopausal levels. J Bone Miner Res 2005;M364:S399., J. Bone Miner. Res., 2005
  • Zoehrer R, Roschger P, Durchschlag E, Fratzl P, Paschalis E, Recker R, Phipps R, Klaushofer K: Effect of 3- and 5-year treatment with risedronate on the bone mineralization density distribution of trabecular bone in human iliac crest biopsies. Bone 2005;36:S420., Bone, 2005
  • Paschalis E, Durchschlag E, Zoehrer R, Roschger P, Fratzl P, Recker R, Phipps R, Klaushofer K: Effects of 3- and 5-year treatment with risedronate on the bone mineral maturity/crystallinity and collagen cross-links as a function of trabecular surface activity. Bone 2005;36:S420-S421., Bone, 2005
  • Dalsky GP, San Martin J, Chen P, Genant HK, Jiang Y, Delmas PD, Eriksen EF: Severity of vertebral fracture reflects deterioration of trabecular bone microarchitecture. NIAMS-ASBMR Bone Quality: What is it and can we measure it? May 2005; 47., NIAMS-ASBMR Bone Quality: What is it and can we measure it?, 2005
  • Faibish D, Myers ER, Recker RR, Boskey AL: Young investigator award recipient: preliminary correlations between fracture risk and IR imaging parameters. NIAMS-ASBMR Bone Quality: What is it and can we measure it? May 2005; 17., NIAMS-ASBMR Bone Quality: What is it and can we measure it?, 2005
  • Recker R, Ensrud K, Diem S, Cheng E, Bare S, Masarachia P, Roschger P, Fratzl P, Klaushofer K, Lombardi A, Kimmel D: Bone histomorphometric findings after 10 years alendronate treatment of postmenopausal women. NIAMS-ASBMR Bone Quality: What is it and can we measure it? May 2005; 36., NIAMS-ASBMR Bone Quality: What is it and can we measure it?, 2005
  • Recker R, Ensrud K, Diem S, Cheng E, Bare S, Masarachia P, Roschger P, Fratzl P, Klaushofer K, Lombardi A, Kimmel D. Normal bone histomorphometry and 3D microarchitecture after 10 years alendronate treatment of postmenopausal women. J Bone Miner Res 2004;19:S45., Journal of Bone and Mineral Research, 2004
  • Recker RR, Kendler DL, Adami S, Hughes C, Dumont E, Schimmer RC, Cooper C. Monthly oral ibandronate significantly reduces bone resorption in postmenopausal osteoporosis: 1-year results from MOBILE. J Bone Miner Res 2004;19:S94., Journal of Bone and Mineral Research, 2004
  • Recker RR, Bare SP, Miller MA, Newman MK, Fox J. Treatment of osteoporotic women with parathyroid hormone 1-84 for 18 months improves cancellous bone formation and structure: a bone biopsy study. J Bone Miner Res 2004;19:S97., Journal of Bone and Mineral Research, 2004
  • Murphy M, Cerchio K, Stoch S, Gottesdiener K, Wu M, Recker R. Effect of MRL123, an orally administered alphaVbeta integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. J Bone Miner Res 2004;19:S99., Journal of Bone and Mineral Research, 2004
  • Liu YZ, Dvornyk V, Lu Y, Shen H, Wilde J, Conway T, Recker RR, Deng HW. Microarray study of circulating monocytes in search for functional genes for osteoporosis. J Bone Miner Res 2004;19:S240-241., Journal of Bone and Mineral Research, 2004
  • Deng HW, Shen H, Liu YJ, Liu PY, Recker RR. Non-replication in genetic studies of complex diseases – lessons learned from osteoporosis. J Bone Miner Res 2004;19:S247., Journal of Bone and Mineral Research, 2004
  • Cullen DM, Akhter MP, Johnson, ML, Morgan S, Recker RR. Ulna loading response altered by the HBM mutation. J Bone Miner Res 2004;19:S396., Journal of Bone and Mineral Research, 2004
  • Haynatzki GR, Stegman MR, Recker RR, Heaney RP. Predictors of incident appendicular fractures in men and women. J Bone Miner Res 2004;19:S428., Journal of Bone and Mineral Research, 2004
  • Emkey R, Felsenberg D, Stepan JJ, Hughes C, Dumont E, Van der Auwera P, Recker RR. Once monthly dosing increases the proportion of patients who respond to oral ibandronate: 1-year results from MOBILE. J Bone Miner Res 2004;19:S447., Journal of Bone and Mineral Research, 2004
  • Recker R, Gallagher R, Amonkar M, Smith J, MacCosbe P. Medication persistence is better with weekly bisphosphonates, but it remains suboptimal. J Bone Miner Res 2004;19:S172., Journal of Bone and Mineral Research, 2004
  • McClung M, Wasnich RD, Recker R, Cauley JA, Ensrud K, Burdeska A, Mahoney P, Hughes C, Chesnut C: Daily oral ibandronate prevents bone loss in postmenopausal women without osteoporosis. ASBMR Annual Meeting, San Antonio, Texas, 2002., Abstract Book, 2002
  • Recker R, Stakkestad JA, Weber T, Cohen S, Delmas P, Schimmer R, Mahoney P, Kilbride J: Non-vertebral fracture benefit from oral ibandronate administered daily or with a unique drug-free interval: results from a pivotal phase III study in postmenopausal osteoporosis (PMO). ASBMR Annual Meeting, San Antonio, Texas, 2002., Abstract Book, 2002
  • McClung M, Wasnich RD, Recker R, Cauley JA, Ensrud K, Burdeska A, Mahoney P, Hughes C, Chesnut C: Daily oral ibandronate prevents bone loss in postmenopausal women without osteoporosis. ASBMR Annual Meeting, San Antonio, Texas, 2002., Abstract Book, 2002
  • Xu FH, Shen H, Liu YJ, Huang QY, Deng HY, Zhao LJ, Conway T, Davies KM, Recker RR, Deng HW: Confirmation of linkage of 17q23 to bone size variation. ASBMR Annual Meeting, San Antonio, Texas, 2002., Abstract Book, 2002
  • Liu YJ, Xu FH, Shen H, Liu YZ, Huang QY, Deng HY, Zhao LJ, Conway T, Davies KM, Recker RR, Deng HW: A confirmation study for quantitative-trait loci for BMD-related obesity phenotypes. ASBMR Annual Meeting, San Antonio, Texas, 2002., Abstract Book, 2002
  • Huang QY, Xu FH, Shen H, Liu YJ, Liu YZ, Deng HY, Zhao LJ, Dvornyk V, Davies KM, Recker RR, Deng HW: Second stage of genome scan for QTLs influencing BMD variation. ASBMR Annual Meeting, San Antonio, Texas, 2002., Abstract Book, 2002
  • Liu YZ, Deng HY, Long JR, Zhang YY, Lu SB, Xu FH, Shen H, Liu YJ, Huang QY, Zhao LJ, Conway T, Recker RR, Deng HW: A confirmation and extension study for linkage to an important complex trait related to osteoporotic fractures- height. ASBMR Annual Meeting, San Antonio, Texas, 2002., Abstract Book, 2002
  • Zhao LJ, Shen H, Elze L, Recker RR, Deng HW: Testing of association and/or linkage for the estrogen receptor-a gene with peak bone mass in US caucasian nuclear families. ASBMR Annual Meeting, San Antonio, Texas, 2002., Abstract Book, 2002
  • Zhang YY, Huang QY, Shen H, Deng HY, Conway T, Recker RR, Deng HW: Dinucleotide repeat (CA) polymorphisms of the IL-6, TNFR2, and CT genes and BMD. ASBMR Annual Meeting, San Antonio, Texas, 2002., Abstract Book, 2002
  • Cullen DM, Akhter MP, Mace D, Johnson ML, Babij P, Recker RR: Bone sensitivity to mechanical loads with the Lrp5 HBM mutation. ASBMR Annual Meeting, San Antonio, Texas, 2002., Abstract Book, 2002
  • Lappe JM, Davies KM, Haynatzki G, Travers-Gustafson D, Recker RR: Prevalence of osteoporosis in rural postmenopausal women. ASBMR Annual Meeting, San Antonio, Texas, 2002., Abstract Book, 2002
  • Allen KM, Anisowicz A, FitzGerald MG, Van Eerdewegh R, Little RD, Keith T, Recker RR, Johnson ML: Polymorphism analysis of LDL receptor-related protein 5 (LRP5). ASBMR Annual Meeting, San Antonio, Texas, 2002., Abstract Book, 2002
  • Shen H, Zhao LJ, Long JR, Zhang YY, Elze L, Recker RR, Deng HW: Testing of association and/or linkage for five candidate genes with peak BMD in US caucasian nuclear families. ASBMR Annual Meeting, San Antonio, Texas, 2002., Abstract Book, 2002
  • Akhter MP, Cullen DM, Wells DJ, Johnson ML, Babij P, Haynatzki GR, Recker RR: Effects of a mutation in the Lrp5 gene on bone biomechanical properties. ASBMR Annual Meeting, San Antonio, Texas, 2002., Abstract Book, 2002
  • Akhter MP, Cullen DM, Wells DJ, Mace DL, Recker RR: Indomethacin suppresses the bone adaptation response to mechanical loading in C57BL/6J mice. ASBMR Annual Meeting, San Antonio, Texas, 2002., Abstract Book, 2002
  • Zhao J, Jiang JY, Recker RR, Draper MW, Genant HK: Iliac three-dimensional trabecular microarchitecture in premenopausal healthy women and postmenopausal osteoporotic women with and without fracture. ASBMR Annual Meeting, San Antonio, Texas, 2002., Abstract Book, 2002
  • Delmas PD, Recker RR, Stakkestad JA, Chesnut III CH, Christiansen C, Hoiseth A, Gilbride J, Schimmer: Antifracture efficacy of oral ibandronate given with a between-dose interval of >2 months in postmenopausal osteoporosis. IBMS-JSBMR First Joint Meeting, Osaka, Japan, 2003., Abstract Book, 2002
  • Akhter MP, Khalil DA, Lucas EA, Galloway DS, Hammond LJ, Smith BJ, Recker R, B. H. Arjmandi BH: Soy isoflavones may enhance bone formation in an aged rat model of male osteoporosis. ASBMR Annual Meeting, San Antonio, Texas, 2002., Abstract Book, 2002
  • Khalil DA, Akhter MP, Juma S, Lucas EA, Galloway DS, Hammond LJ, Soung D, Smith BJ, Recker R, Arjmandi BH: The combination of vitamin E and soy protein exerts added skeletal benefits in an aged rat model of male osteoporosis. ASBMR Annual Meeting, San Antonio, Texas, 2002., Abstract Book, 2002
  • Recker R, Stakkestad JA, Weber T, Cohen S, Delmas P, Schimmer R, Mahoney P, Kilbride J. Non-vertebral fracture benefit from oral ibandronate administered daily or with a unique drug-free interval: results from a pivotal phase III study in postmenopausal osteoporosis (PMO). ASBMR Annual Meeting, San Antonio, Texas, 2002., Not Applicable, 2002
  • McClung M, Wasnich RD, Recker R, Cauley JA, Ensrud K, Burdeska A, Mahoney P, Hughes C, Chesnut C. Daily oral ibandronate prevents bone loss in postmenopausal women without osteoporosis. ASBMR Annual Meeting, San Antonio, Texas, 2002., Not Applicable, 2002
  • Xu FH, Shen H, Liu YJ, Huang QY, Deng HY, Zhao LJ, Conway T, Davies KM, Recker RR, Deng HW. Confirmation of linkage of 17q23 to bone size variation. ASBMR Annual Meeting, San Antonio, Texas, 2002., Not Applicable, 2002
  • Akhter MP, Khalil DA, Lucas EA, Galloway DS, Hammond LJ, Smith BJ, Recker R, B. H. Arjmandi BH. Soy isoflavones may enhance bone formation in an aged rat model of male osteoporosis. ASBMR Annual Meeting, San Antonio, Texas, 2002., Not Applicable, 2002
  • Zhao J, Jiang JY, Recker RR, Draper MW, Genant HK. Iliac three-dimensional trabecular microarchitecture in premenopausal healthy women and postmenopausal osteoporotic women with and without fracture. ASBMR Annual Meeting, San Antonio, Texas, 2002., Not Applicable, 2002
  • Akhter MP, Cullen DM, Wells DJ, Mace DL, Recker RR. Indomethacin suppresses the bone adaptation response to mechanical loading in C57BL/6J mice. ASBMR Annual Meeting, San Antonio, Texas, 2002., Not Applicable, 2002
  • Akhter MP, Cullen DM, Wells DJ, Johnson ML, Babij P, Haynatzki GR, Recker RR. Effects of a mutation in the Lrp5 gene on bone biomechanical properties. ASBMR Annual Meeting, San Antonio, Texas, 2002., Not Applicable, 2002
  • Shen H, Zhao LJ, Long JR, Zhang YY, Elze L, Recker RR, Deng HW. Testing of association and/or linkage for five candidate genes with peak BMD in US caucasian nuclear families. ASBMR Annual Meeting, San Antonio, Texas, 2002., Not Applicable, 2002
  • Allen KM, Anisowicz A, FitzGerald MG, Van Eerdewegh R, Little RD, Keith T, Recker RR, Johnson ML. Polymorphism analysis of LDL receptor-related protein 5 (LRP5). ASBMR Annual Meeting, San Antonio, Texas, 2002., Not Applicable, 2002
  • Liu YJ, Xu FH, Shen H, Liu YZ, Huang QY, Deng HY, Zhao LJ, Conway T, Davies KM, Recker RR, Deng HW. A confirmation study for quantitative-trait loci for BMD-related obesity phenotypes. ASBMR Annual Meeting, San Antonio, Texas, 2002., Not Applicable, 2002
  • Khalil DA, Akhter MP, Juma S, Lucas EA, Galloway DS, Hammond LJ, Soung D, Smith BJ, Recker R, Arjmandi BH. The combination of vitamin E and soy protein exerts added skeletal benefits in an aged rat model of male osteoporosis. ASBMR Annual Meeting, San Antonio, Texas, 2002., Not Applicable, 2002
  • Huang QY, Xu FH, Shen H, Liu YJ, Liu YZ, Deng HY, Zhao LJ, Dvornyk V, Davies KM, Recker RR, Deng HW. Second stage of genome scan for QTLs influencing BMD variation. ASBMR Annual Meeting, San Antonio, Texas, 2002., Not Applicable, 2002
  • Liu YZ, Deng HY, Long JR, Zhang YY, Lu SB, Xu FH, Shen H, Liu YJ, Huang QY, Zhao LJ, Conway T, Recker RR, Deng HW. A confirmation and extension study for linkage to an important complex trait related to osteoporotic fractures- height. ASBMR Annual Meeting, San Antonio, Texas, 2002., Not Applicable, 2002
  • Zhao LJ, Shen H, Elze L, Recker RR, Deng HW. Testing of association and/or linkage for the estrogen receptor-a gene with peak bone mass in US caucasian nuclear families. ASBMR Annual Meeting, San Antonio, Texas, 2002., Not Applicable, 2002
  • Cullen DM, Akhter MP, Mace D, Johnson ML, Babij P, Recker RR. Bone sensitivity to mechanical loads with the Lrp5 HBM mutation. ASBMR Annual Meeting, San Antonio, Texas, 2002., Not Applicable, 2002
  • Zhang YY, Huang QY, Shen H, Deng HY, Conway T, Recker RR, Deng HW. Dinucleotide repeat (CA) polymorphisms of the IL-6, TNFR2, and CT genes and BMD. ASBMR Annual Meeting, San Antonio, Texas, 2002., Not Applicable, 2002
  • Lappe JM, Davies KM, Haynatzki G, Travers-Gustafson D, Recker RR. Prevalence of osteoporosis in rural postmenopausal women. ASBMR Annual Meeting, San Antonio, Texas, 2002., Not Applicable, 2002
  • Eastell R, Adachi J, Harper K, Sarkar S, Delmas P, Ensrud K, Gennari C, Reginster J-Y, Pols H, Recker R, Harris S, Wu W, Henant H. Early onset and sustained efficacy of raloxifene on incident vertebral fractures in postmenopausal women with osteoporosis: 4-year results from the MORE trial, IBMS/ECTS, 2001
  • Zhang HT, Deng HW, Shen H, Xu FH, Li Y, Conway T, Recker RR. Tests of linkage and/or association of genes for vitamin D receptor, osteocalcin and parathyroid hormone with bone mineral density (BMD). J Bone Miner Res, 16:S472, 2001., Not Applicable, 2001
  • Recker RR, Johnson ML, Davies KM, Recker SM, Heaney RP. Autosomal dominant high bone mass: the phenotype. J Bone Miner Res, 16:S470, 2001, Not Applicable, 2001
  • Akhter MP, Haynatzki GR, Hull TW, Cullen DM, Recker RR, Gairola GC. Tobacco smoke exposure and bone biomechanical properties. J Bone Miner Res, 16:S388, 2001, Not Applicable, 2001
  • Akhter MP, Hull TW, Gentry-Nielsen MF, Cullen DM, Recker RR. Bone strength properties with tobacco smoke and ethanol exposure in rats. J Bone Miner Res, 16:S387, 2001, Not Applicable, 2001
  • Gong G, Haynatzki GR, Recker RR, Genetic distance between candidate gene and bone mineral density-affecting gene loci. J Bone Miner Res, 16:S351, 2001., Not Applicable, 2001
  • Recker RR, Coble T, Burshell A, Lombardi A, Rodan G, Kimmel DB, Yates J, Effect of alendronate and estrogen replacement on periosteal bone formation in postmenopausal women. J Bone Miner Res, 16:S180, 2001., Not Applicable, 2001
  • Deng HW, Xu FH, Shen H, Zhang HT, Deng HY, Conway T, Huang QY, Chen J, Xia QH, Liu YZ, Liu YJ, Davies KM, Recker RR. A large-scale whole-genome scan suggests several genomic regions containing QTLs for BMD variation. J Bone Miner Res, 16:S167, 2001., Not Applicable, 2001
  • Shen H, Xu FH, Zhang HT, Deng HY, Conway T, Xia QH, Chen J, Liu YZ, Liu YJ, Huang QY, Davies KM, Recker RR, Deng HW. A large-scale whole-genome linkage scan identifies several genomic regions with underlying bone size variation. J Bone Miner Res,16:S152, 2001., Not Applicable, 2001
  • Jiang Y, Zhao J, Recker RR, Draper MW, Genant HK. Longitudinal transmenopausal changes in three-dimensional trabecular microarchitecture and connectivity of human iliac crest bone biopsies. J Bone Miner Res,16:S150, 2001., Not Applicable, 2001
  • Lappe JM, Stubby JA, Davies KM, Recker RR, Exercise without sufficient calcium does not increase rate of bone mass accrual I pubertal females. J Bone Miner Res, 16:S138, 2001., Not Applicable, 2001
  • Haynatzki GR, Dunlay RW, Lappe JM, Stegman MR, Recker RR. Use of quantitative ultrasound in managing renal osteodystrophy. J Bone Miner Res, 16:S470, 2001, Not Applicable, 2001
  • Xu FH, Deng HW, Livshits G, Yakovenko K, Conway T, Davies KM, Deng HY, Recker RR. Evidence for a major gene for bone mineral density/content in human pedigrees identified via probands with extreme bone mineral density. J Bone Miner Res, 16:S472, 2001, Not Applicable, 2001

Editing and Reviews

  • Roth K. (Review by Dr. Recker): Physiology of Bone Metabolism: 2006., Neurosurgery Clinics North America, 2006
  • Heaney RP, Recker RR: Combination and sequential therapy for osteoporosis: Letter to Editor. N Engl J Med 353:625-625, 2005., New England Journal of Medicine, 2005
  • Liu Y, Xu F, Recker RR, Deng HW: Letter to the editor: Interpretation of genetic linkage findings. J Bone Miner Res 18:2077-2078, 2003., Journal of Bone and Mineral Research, 2003
  • Heaney RP, Recker RR, Lappe JM: Letter to the editor: Effects of calcium supplementation on serum lipid levels in postmenopausal women. Am J Med 114:620-621, 2003., American Journal of Medicine, 2003

Presentations

  • Dempster D, Zhou H, Recker R, Brown J, Recknor C, Lewiecki M, Miller P, Rao S, Kendler D, Lindsay R, Krege J, Alam J, Taylor K, Ruff V. Modeling- and Remodeling-Based Bone Formation in the Anabolic Versus Antiresorptive (AVA) Study in Postmenopausla Women with Osteoporosis. Poster presented at the World Congress Osteoprosis, Osteoarthritis, & Musculoskeletal Disease, Florence, Italy March 23-26, 2017, 2017
  • Lappe, J., Travers-Gustafson, D., Garland, C., Heaney, R., Recker, R., and Watson, P. Vitamin D3 and calcium supplementation significantly decreases cancer risk in older women. Oral presentation presented as a late-breaking abstract at the American Public Health Association Annual meeting , Denver, CO, October 29 – November 2, 2016, 2016
  • Singh S, Recker R. Curious case of Cretinism and Resistance to Thyroid Hormone(RTH): Is the Cretinism result of misdiagnosis or due to mutation itself? Poster presented at the 86th Annual Meeting of the ATA in Denver, Colorado from September 21 - 25, 2016, 2016
  • Dempster D, Zhou H, Recker R, Brown J, Recknor C, Lewiecki E, Miller P, Rao S, Kendler D, Lindsay R, John K, Alam J, Taylor K, Ruff V. Longitudinal Changes in Modeling-and Remodeling-Based Bone Formation with an Anabolic vs. an Antiresorptive Agent in the AVA Osteoporosis Study. Oral presentation at the ASBMR 2016 Annual Meeting, Atlanta, GA, September 16-19, 2016, 2016
  • Greenspan S, Singer A, Recker R, Lee D, Karp S, Marchand B, Zeldow D, Stern L. A Demonstration Study of the Fracture Liaison Service (FLS) Model of Care for Patients with Osteoporotic Fractures. Poster Presented at the ASBMR 2016 Annual Meeting, Atlanta, GA, September 16-19, 2016., 2016
  • Recker R, Dempster D, Langdahl B, Ellis G, de Villiers T, Cohn D, Doleckyj S, Giezek H, Santora A, Duong L. Effects of Odanacatib on Transilial Cortical Remodeling/Modeling and Microarchitecture in Postmenopausal Women with Osteoporosis: 5-Year Data from the Extension of the Phase 3 Long-Term Odanacatib Fracture Trial (LOFT). Oral presentation at the ASBMR 2016 Annual Meeting, Atlanta, GA, September 16-19, 2016, 2016
  • Evans D, Alliston T, Zhang B, Youngren J, Recker R, Lappe J, Reppe S, Lang T. Gentic Risk of Hip Fracture Due to Bone Quality Defict. Poster presented at the ASBMR 2016 Annual Meeting, Atlanta, GA, September 16-19, 2016, 2016
  • Cohen A, Kamanda-Kosseh M, McMahon D, Dempster D, Zhou H, Lappe J, Recker R, Stubby J, Bucovsky M, Shane E. Biopsy-based bone remodeling characteristics of premenopausal women with idiopathic osteoporosis on selective serotonin reuptake inhibitors (SSRIs). Poster presented at the ASBMR 2016 Annual Meeting, Atlanta, GA, September 16-19, 2016, 2016
  • Akhter M, Hugenroth B, Recker R. Lacunar Void Properties in Bone Tissue from Women Treated with Alendronate. Poster presented at the ASBMR 2016 Annual Meeting, Atlanta, GA, September 16-19, 2016, 2016
  • Rizzo A, Farlay D, Akhter M, Boskey A, Recker R, Lappe J, Boivin G. Variables Reflecting the Mineralization of Bone Tissue from Fracturing versus Non-fracturing Postmenopausal Women. Poster presented at the ASBMR 2016 Annual Meeting, Atlanta, GA, September 16-19, 2016, 2016
  • Recker, R. Nanno-Indentation and FTIRI in Bone Quality. Osteoporosis Research Center Friday Conference. Creighton University Medical Center, February 5, 2016., 2016
  • Recker R. State-of-the-art in histomorphometry, including selected aspects of innovations in osteoporosis treatment. Presented at the Annual Autumn conference of the Austrian Society for Bone and Mineral Research, December 4, 2015., 2015
  • Recker R. Osteoporosis medications. Presented at Creighton University osteoporosis Research Center Bone health Group, Wednesday, November 11, 2015, 2015
  • Recker R. Osteoporosis Research Center. Health Sciences Library Staff Development Session, Wednesday, November 11, 2015., 2015
  • Recker R. Osteoporosis. Presented at Creighton university medical Center Division of osteoporosis/Endocrinology, Grand Rounds Conference, October 20, 2015., 2015
  • Cohen A, Manavalan J, Kousteni S, Recker R, Lappe J, Dempster D, Zhou H, McMahon D, Bucovsky M, Kamanda-Kosseh M, Stubby J, Shane E. Circulating osteogenic progenitors (COPs) and COP surface IGF-1 receptor density predict tissue-based bone formation rate and response to teriparatide (TPTD) in premenopausal women with idiopathic osteoporosis (IOP). ASBMR 2015 Annual Meeting, Seattle, WA, October 9-12, 2015., 2015
  • Vennin S, Desyatova A, Turner J, Recker R, Akhter M. Intrinsic material property differences in bone tissue from fracturing vs non-fracturing women. ASBMR 2015 Annual Meeting, Seattle, WA, October 9-12, 2015., 2015
  • Boskey A, Spevak L, Boskey ER, Recker RR. Age Matters: Correlating Age with Spectroscopic Markers of Fragility Risk. ASBMR 2015 Annual Meeting, Seattle, WA, October 9-12, 2015., 2015
  • Dempster D, Zhou H, Recker R, Brown J, Recknor C, Lewiecki E, Miller P, Rao S, Kendler D, Drege J, Alam J, Taylor K, Janos B, Ruff, V. Anabolism Versus Antiresorption (AVA Study): A comparison of the mechanism of action (MOA) of Teriparatide (TPTD) and Denosumab (DMAb) in Postmenopausal Women with Osteoporosis using quadruple fluorochrome labeled bone histomorphometry. ASBMR 2015 Annual Meeting, Seattle, WA, October 9-12, 2015., 2015
  • Cohen A, Kamanda-Kosseh M, Zhou H, Dempster D, Bucovsky M, Stubby J, Recker R, Lappe J, Shane E. Pregnancy and lactation associated osteoporosis (PLO): Similar bone structure and lower bone remodeling than idiopathic osteoporosis. ASBMR 2015 Annual Meeting, Seattle, WA, October 9-12, 2015., 2015
  • Cleland T, Cohen A, Dempster D, Recker R, Lappe J, Zhou H, Shane E, Vashishth D. Advanced Glycation End-products are Higher in Trabecular Bone from Premenopausal Women with Idiopathic Osteoporosis. ASBMR 2015 Annual Meeting, Seattle, WA, October 9-12, 2015., 2015
  • Binkley N, Lappe J, Davies K, Recker R. Vitamin D Status and Bone Mineralization: A Histomorphometric Analysis. Accepted for oral presentation. ASBMR 2015 Annual Meeting, Seattle, WA, October 9-12, 2015., 2015
  • Joven MH, Armas LAG, Whyte MP, Recker RR, Mumm S. Adult Hypophosphatasia Presenting with a Low Bone Remodeling Rate. Accepted for presentation at the AACE Annual Meeting, Nashville, TN May 14-15, 2015., 2015
  • Paschalis EP, Gamsjaeger S, Hassler N, Brozek W, Fratzl P, Eriksen EF, Rauch F, Glorieux FH, Shane E, Dempster D, Recker R, Klaushofer K. Aging vs postmenopausal osteoporosis: Turnover-independent bone composition maturation kinetics at actively forming trabecular surfaces. Submitted for presentation at the European Calcified Tissue Society (ECTS) and the International Bone and Mineral Society (IBMS), Rotterdam, The Netherlands, April 25-28, 2015., 2015
  • Cohen A, Manavalan S, Kousteni S, Recker R, Lappe J, Dempster D, McMahon D, Bucovsky M, Kamanda-Kosseh M, Stubby J, Shane E. Circulating osteoblast progenitors and IGF-1 receptor density on these cells correlate with bone formation on transiliac biopsies and predict response to teriparatide in premenopausal women with idiopathic osteoporosis. Accepted for poster presentation at the Endocrine’s Society Annual Meeting, San Diego, CA, March 5-8, 2015., 2015
  • Cohen A, Dempster D, Zhou H, Recker R, Lappe J, Cremers S, Muller R, Zwahlen A, Kamanda-Kosseh M, Bucovsky M, Stein E, Nickolas T, Shane E. Healthy premenopausal women with low HDL (less than 50 mg/dL) have significantly lower trabecular bone volume and bone formation rate. Accepted for poster presentation at the Endocrine’s Society Annual Meeting, San Diego, CA, March 5-8, 2015., 2015
  • Cohen A, Manavalan S, Kousteni S, Recker R, Lappe J, Dempster D, McMahon D, Bucovsky M, Kamanda-Koseh M, Stubby J, Shane E. Early increase in IGF-1 receptor density on circulating osteogenic progenitor cells predict responsiveness to teriparatide. ASMBR 2014 Annual Meeting, Houston, TX September 2014., 2014
  • Boskey A, Spevak L, Watson P, Bare S, Recker R. Tissue heterogeneity determined by FTIR imaging decreases with increasing fracture count. ASBMR 2014 Annual Meeting, Houston, TX September 2014., 2014
  • Benson C, Chiang A, Hu L, Jahangir A, Mitlak B, Recker R, Robins D, Sowa H, Sipos A. Effects of 2 years of treatment with romosozumab followed by 1 year of denosumab or placebo in postmenopausal women with low bone mineral density. ASBMR 2014 Annual Meeting, Houston TX September 2014., 2014
  • Rosauer B, Akhter M, Kimmel D, Lappe J, Recker R. Osteocyte lacunar density is breed related in mice. ASBMR 2014 Annual Meeting, Houston, TX September 2014., 2014
  • Armas L, Recker R. Type 1 diabetes mellitus effects on bone: results of histomorphometric analysis. ASBMR 2014 Annual Meeting, Houston, TX September 2014., 2014
  • Recker R, Dempster D, de VilliersT, langdahl B, Miller P, Valter I, Zerbini C, Cohn D, Doleckyj S, Duong L, Scott B, Verbruggen N, Santora A. Effects of odanacatib on bone structure and quality in postmenopausal women with osteoporosis: Results from the phase III long-term odanacatib fracture trial (LOFT). ASBMR 2014 Annual Meeting, Houston, TX September 2014., 2014
  • Akhter M, Cullen D, Danforth J, Alvarez G, Hackfort B, Recker R. Biomechanical analyses of bone tissue damage from fatigue loading in vivo. ASBMR 2014 Annual Meeting, Houston, TX September 2014., 2014
  • Cohen A, Manavalan JS, Recker R, Lappe L, Dempster D, McMahon DJ, Kousteni S, Bucovsky M, Kamanda-Kosseh M, Stubby J, Shane E. Early increases in circulating osteogenic progenitor (COP) cells and COP cell surface IGF-1 receptor density in response to teriparatide. ASBMR 2014 Annual Meeting, Houston, TX September 2014., 2014
  • Carballido-Gamio J, Bonaretti S, Saeed I, Harnish R, Recker R, Burghardt A, Keyak J, Harris T, Sundeep K, Lang T. Automatic QCT quantification of the proximal femur: vBMD, bone volume, cortical bone thickness and finite element modeling. ASBMR 2014 Annual Meeting, Houston, TX September 2014., 2014
  • Cohen A, Kamanda-Kosseh M, Recker R, Lappe J, Dempster D, Zhou H, Cremers S, Bucovsky M, Stubby J, Shane E. Characteristics of premenopausal women with idiopathic osteoporosis who experience significant bone loss after teriparatide cessation. ASBMR 2014 Annual Meeting, Houston, TX September 2014., 2014
  • Tribble MB, Cohen A, deBakker C, Lappe J, Recker R, Nishiyama K, Rubin M, Bilezikian J, Shane E, Liu XS. Increased endocortical formation and periosteal resorption at the distal tibia in premenopausal women with idiopathic osteoporosis treated with 18 months of teriparatide. ASBMR 2014 Annual Meeting, Houston TX September 2014., 2014
  • Farlay D, Armas L, Gineyts E, Recker R, Boivin G. Pentosidine and degree of mineralization are increased in bone from fractured-patients with type 1 diabetes mellitus. ASBMR 2014 Annual Meeting, Houston, TX September 2014., 2014
  • Gamsijaeger S, Brozek W, Recker R, Klaushofer K, Paschalis,EP. Transmenopausal changes in cortical bone quality. ASMBR 2014 Annual Meeting, Houston, TX September 2014., 2014
  • Cullen D, Akhter M, Danforth J, Alvarez G, Hackfort B, Recker R. Inflammatory signals associated with in vivo fatigue damage. ORS 60th Annual Meeting, New Orleans, LA, March 2014., 2014
  • Tarasova V, Nahar N, Dietz N, Recker R, Anderson R. Unique occurrence and course of Graves in a patient with PTEN hamartoma tumor syndrome. ATA 83rd Annual Meeting, Puerto Rico. Thyroid 23(1): 177 Oct. 2013., 2013
  • Dempster D, Zhou H, Recker R, Brown J, Bolognese M, Recknor C, Kendler D, Lewiecki EM, Rao S, Miller P, Woodson G, Lindsay R, Binkley N, Alam J, Ruff V, Janos B, Taylor K. A longitudinal study of skeletal Histomorphometry in subjects on Teriparatide (TPTD) or Zoledronic acid (ZOL), the SHOTZ study. ASBMR 35th Annual Meeting, Baltimore, MD 2013., 2013
  • Nishiyama K, Wang J, Young P, Recker R, Lappe J, Cremers S, Guo X, Shane E, Cohen A. Teriparatide is associated with improved microarchitecture and estimated bone strength in premenopausal women with idiopathic osteoporosis: An HR-pQCT study. ASBMR 35th Annual Meeting, Baltimore, MD 2013., 2013
  • Akhter M, Danforth J, Kimmel D, McElwee J, Furia M, Pennypacker B, Duong LT, Recker R, Opiteck G. Bone structure and strength in three mouse crosses as a function of strain. ASBMR 35th Annual Meeting, Baltimore, MD 2013., 2013
  • Kepley A, Shen W, Mayer L, Shane E, Weigel J, Kenney L, Young P, Zhang C, Recker R, Lappe J, Cohen A. Premenopausal women with idiopathic osteoporosis and those with anorexia nervosa have similar bone structural defects but differ in terms of marrow fat. ASBMR 35th Annual Meeting, Baltimore, MD 2013, 2013
  • Farlay D, Armas L, Martin A-S, Recker R, Boivin G. Bone material properties are impaired in fractured -patients with type 1 diabetes mellitus. ASBMR 35th Annual Meeting, Baltimore, MD 2013., 2013
  • Cohen A, Costa A, Recker R, Lappe J, Cremers S, Dempster D, Zhou H, Zwahlen A, Miller R, Stein E, Nickolas T, Rosen C, Shane E. Lower bone volume fraction and bone formation rate in premenopausal women with abdominal obesity are associated with less physical activity and higher serum sclerostin. ASBMR 35th Annual Meeting, Baltimore, MD 2013., 2013
  • Boskey A, Spevak L, Mandair G, Bare S, Recker R, Morris M. Correlating FTIRI and raman parameters using iliac crest biopsies. ASBMR 35th Annual Meeting, Baltimore, MD 2013, 2013
  • Novel therapies for osteoporosis: Sun Valley Workshop, Sun Valley ID., 2005
  • A 5 year randomized trial of the long-term efficacy and safety of alendronate: the Fit Long-term EXtension (FLEX): Merck, Chicago IL., 2005
  • Clinical review of the FLEX data: Merck, Chicago IL., 2005
  • How do anti-resptive agents prevent fractures with so little increase in BMD? CME, Omaha NE., 2005
  • What's new in vitamin D? CME, Omaha NE., 2005
  • Controversies in bone and mineral metabolism To D or not to D - That is the question!: NKF, Washington DC., 2005
  • Bone quality: What is it and can we measure it? NIH Bone Quality, Washington DC., 2005
  • Current trends of osteoporosis: AMCP, Denver CO., 2005
  • Efficacy of monthly BNIVA (ibandronate sodium) tablets: GSK, Dallas TX., 2005
  • Current concepts in the prevention and treatment of osteoporosis: UMKC, Kansas City MO., 2005
  • Bone remodeling and the BMD paradigm: NOF, Washington DC., 2005
  • Genetic research in osteoporosis: Where are we? Where should we go next? P&G, Cincinnati OH., 2005
  • Current concepts in the prevention and treatment of osteoporosis: University of Cincinnati, Cincinnati OH., 2005
  • Current management of osteoporosis: Roche, Las Vegas NV., 2005
  • Therapeutic agents: GSK-Roche, Raleigh NC., 2004
  • Diagnostic and public health considerations in osteoporosis: GSK-Roche, Raleigh NC., 2004
  • Permissible exposure limit (PEL) for bone: NASA, Houston TX., 2004
  • Cancellous bone formation and structure: a bone biopsy study: Grand Rounds, Omaha NE., 2004
  • Bone quality and fracture risk: ACR, San Antonio TX., 2004
  • Investigational uses of ibandronate in treatment of osteoporosis: WONCA, Orlando FL, 2004
  • Normal bone histomorphometry and 3D microarchitecture after 10 years alendronate treatment of postmenopausal women. ASBMR - Seattle, WA., 2004
  • Update of bone quality research and its current and future clinical application. ASBMR - Seattle, WA., 2004
  • Calcium absorption: techniques and interpretation. ASBMR - Seattle, WA., 2004
  • Current and new therapies in osteoporosis: ASBMR, Seattle WA., 2004
  • New therapies in osteoporosis. ASBMR - Seattle, WA., 2004
  • Bone microarchitecture after 10 years of alendronate treatment: the FLEX study, ASBMR, Seattle WA., 2004
  • How do you obtain transilial bone biopsies: What information can you learn from them? Grand Rounds, Novartis, Newark NJ., 2004
  • Genetic research in osteoporosis: Where are we? Where should we go next? Merck, Philadelphia., 2004
  • Osteoporosis in Family Practice: Current concepts in the prevention and treatment of osteoporosis: Morrison Seminar Room., 2004
  • Osteoporosis in Family Practice: Current concepts in the prevention and treatment of osteoporosis, Lincoln, NE., 2004
  • Genetic Research in osteoporosis: Where are we? Where should we go next?: Endocrine Research Conference, New York., 2004
  • Genetic Research in osteoporosis: Where are we? Where should we go next?: Metropolitan Bone Club, New York., 2004
  • How does bone turnover explain fracture risk?: Bone Rounds, Columbia University., 2004
  • Osteoporosis: Updated to 2004: Prevention and treatment of osteoporosis, Columbia University., 2004
  • Milk-Alkali syndrome due to tums: BRC01 CME program., 2004
  • Current concepts in the prevention and treatment of osteoporosis: Grand Rounds, Department of Orthopaedic Surgery, UNMC, 2004
  • The clinical trials of ibandronate results: BRC01 CME program., 2004
  • Activation frequency, what is it telling us?: BRC01 CME program., 2004
  • Ostoeporosis: Updated to 2003: Nebraska Academy of Family Practice, Lincoln, NE., 2003
  • Genetic Research in Osteoporosis: State of the Art-2003: Massey Lecture, University of North Dakota., 2003
  • Protecting bone & minimizing fracture risk after age 40: Nutritional perspective, University of North Dakota., 2003
  • Daily and intermittent oral ibandronate : an evaluation of bone histomorphometry in postmenopausal osteoporosis. ACR/ARHP Annual Scientific Meeting, Orlando, Florida, 2003., 2003
  • Genetic Research in Osteoporosis: Where are we? Where should we go next?: Internation Conference on Osteoporosis and Bone Research, Beijing, China., 2003
  • Bone biology fundamentals; modeling and remodeling; Pittsburgh Bone Symposium, Pittsburgh, PA., 2003
  • Bone Quality and Fracture Protection with Risedronate: ASBMR, August 2003., 2003
  • Transmenopausal and age-related changes in bone remodeling: activation frequency in transilial bone biopsies; Proctor & Gamble, Cincinnati, OH., 2003
  • Transmenopausal and age-related changes in bone remodeling: activation frequency in transilial bone biopsies; Sun Valley Hard Tissue Workshop, Sun Valley, ID., 2003
  • Endocrine Society 85th Annual, Philadelphia PA, 2003
  • Mary Greeley Medical Center, Ames IA, 2003
  • Novartis/Zoledronic Acid Advisory Board, Phoenix AZ, 2003
  • Novartis Roundtable, Phoenix AZ, 2003
  • National Institutes of Health (NIH) Grand Rounds, Bethesda MD, 2002
  • Endocrine Grand Rounds (Harvard), Boston MA, 2002
  • CME, Country Club, Lincoln, NE, 2002
  • National Advisory Board for Osteoporosis (Lilly), Chicago IL, 2002
  • P & G, Cincinnati OH, 2002
  • University of New Mexico, Albuquerque NM, 2002
  • Women's Health Conference, Omaha NE, 2002
  • Orthopaedic Forum, Council Bluffs IA, 2002
  • ASBMR Annual Meeting, San Antonio, TX; September 2002., 2002
  • ASBMR Annual meeting, San Antonio TX, 2002
  • Merck External Advisory Board, Philadelphia PA, 2002
  • Sun Valley Workshop, Sun Valley ID, 2002
  • University of Oklahoma, Oklahoma City OK, 2002
  • Site Visit, Bethesda MD, 2002
  • ASBMR Summer Council, June 26-28, 2002, Washington, DC, 2002
  • World Congress on Osteoporosis, May 10-14, 2002, Lisbon, Portugal, 2002
  • NIAMS Coalition Day, April 16-17, 2002, Washington, DC, 2002
  • ASBMR Winter Council, January 25-26, 2002, Washington, DC, 2002
  • NIAMS Coalition Day, January 9, 2002, Washington, DC, 2002
  • Topic TBA, November 27-29, 2001, NJ, 2001
  • ASBMR Management Seminar, November 19-20, 2001, Washington, DC (Tyson's Corner), 2001
  • National Scientific Osteoporosis Advisory Board, November 16-18, 2001, San Francisco, CA, 2001
  • Skeletal Genetics: The Next Decade, October 29-31, 2001, National Institutes of Health, Washington, DC, 2001
  • Genetic Regulation of Bone Mass and Risk of Fractures, VIII Spanish Bone and Mineral Society, October 20-27, 2001, Menorca, Spain, 2001
  • Presentation of Abstract: The Effect of Alendronate and Estrogen Replacement on Periosteal Bone Formation, ASBMR Annual Meeting, October 16, 2001, Phoenix, AZ, 2001
  • Special Session for Allied Health Professionals--High Bone Mass, ASBMR Annual Meeting, October 13, 2001, Phoenix, AZ, 2001
  • The Genetics of Osteoporosis, ASBMR Annual Meeting, October 13, 2001, Phoenix, AZ, 2001
  • Faculty Slide Review, ASBMR, October 12, 2001, Phoenix, AZ, 2001
  • ASBMR Press Conference, October 12, 2001, Phoenix Civic Plaza, Phoenix, AZ, 2001
  • Protecting Bone Health with Lower Hormone Replacement Therapy Doses, ASBMR Annual Meeting, October 12, 2001, Phoenix, AZ, 2001
  • American Society for Bone and Mineral Research Annual Meeting, October 10-16, 2001, Phoenix, AZ, President Elect, 2001
  • Bone Biopsy Processing, September 29-30, 2001, San Francisco, CA, 2001
  • Bone Biopsy Processing, September 15-16, 2001, Orlando, FL, 2001
  • Exercise Kids Study, September 10-11, 2001, Bethesda, MD, 2001
  • Ibandronate Clinical Update Meetings, September 7-8, 2001, San Diego, CA, 2001
  • Ibandronate Clinical Update Meetings, August 30-September 2, 2001, Geneva, Switzerland, 2001
  • 31st International Sun Valley Hard Tissue Workshop Co-Organizer, August 6-10, 2001 Osteoporosis Workshop, Sun Valley, ID, August 10, 2001, 2001

Awards and Honors

  • O’Brien Endowed Chair in Health Sciences Award, Creighton University, 2016
  • Crystal Caduceus Award, Creighton University Medical Alumni Advisory Board, 2016
  • METHODS FOR DETECTING GENES ASSOCIATED WITH HEIGHT, PEAK BONE MINERAL DENSITY, AND/OR BODY MASS PROPERTIES (Patent No: 60/539,364), 2004
  • HIGH BONE MASS GENE OF 11Q13.3 (Patent No: 10/731,739), 2003
  • Federic C. Bartter Award, ASBMR, September 2003, 2003
  • METHODS FOR DETECTING GENES ASSOCIATED WITH WRIST BONE SIZE AND OTHER BONE PROPERTIES AND GENES ASSOCIATED WITH (Patent No: 60/502,397), 2003
  • METHODS FOR DETECTING GENES ASSOCIATED WITH BONE PROPERTIES AND OR HEIGHT (Patent No: 60/405,672), 2003
  • METHODS FOR DETECTING GENES ASSOCIATED WITH BONE PROPERTIES AND/OR HEIGHT (Patent No: US03/26657), 2003
  • Method for Detecting Genes Associated with Bone Properties, Height and/or Body Mass Properties (Patent No: 10/200,570), 2002
  • Method for Detecting Genes Associated with Bone Properties, Height and/or Body Mass Properties (Patent No: PCT/US03/23293), 2002
  • BONE MODULATION THROUGH GENES ON CHROMOSOME 22 (Patent No: 10/094598), 2002
  • LINKAGE &/OR ASSOCIATION OF GENES WITH BONE PROPERTIES &/OR OBESITY (Patent No: 60/336,829), 2001
  • QTL'S FOR BONE MINERAL DENSITY AND BONE SIZE VARIATION (Patent No: 60/306,690), 2001
  • BONE MODULATION THROUGH GENES ON CHROMOSOME 12 (Patent No: 60/215.578 ), 2001
  • HIGH BONE MASS GENE OF 11Q13.3 (Patent No: 09/543,771), 2000
  • HIGH BONE MASS GENE OF 11Q13.3 (Patent No: 09/544,395), 2000